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High  performance  liquid  chromatography  (HPLC)  is  the  most  widely  used 
separation technique within the pharmaceutical industry. Due to the growing need for 
high  speed  and  high  quality  separations  other  techniques,  such  as  supercritical  fluid 
chromatography (SFC), are now being considered. The key advantage of SFC is minimal 
solvent waste, which is particularly important in preparative SFC, leading to fast sample 
recovery. Hence it is important to explore whether SFC, which promises to be cheaper 
and more environmentally friendly than conventional HPLC, can be applied more widely 
as a complementary method.  
SFC coupled to mass spectrometry, with an electrospray ion source, was used to 
analyse diverse series of test compounds. The ionisation of samples in the absence of 
high  voltage,  i.e.  ionisation  voltages,  was  observed  when  a  SFC  was  coupled  to 
electrospray  ionization  (ESI)  source.  This  novel  ionisation  process  was  further 
investigated and an attempt was made to explain this ionisation phenomenon and the 
improved  sensitivity  quantified.  To  probe  this  ionization  mechanism,  specific  test 
compounds were analysed and data acquired with high voltages on (electrospray) or off 
(Novospray). Ammonium acetate and formic acid were introduced as buffer to see if 
Novospray  ionization  is thermo  spray  type  or  driven  by  charged  residue  model. The 
Novospray data was comparable or better than the classical ESI and atmospheric pressure 
chemical  ionization  (APCI)  methods.  The  ionisation  is  neither  thermospray  type  nor 
driven by charged residue model. Yet another possibility was sonic spray, where the ion 
intensity strongly depends on the gas flow velocity consentient with high pressure flow 
from SFC. 
One of the objectives of this project has been to determine whether a generic set 
of rules can be applied to choosing the best technique for the separation and analysis of a 
given sample based on the chemistries of compounds involved. In an attempt to develop 
generic  analytical  and  preparative  methods,  a  diverse  series  of  test  compounds  were 
analyzed  on  different  stationary  phase  columns  with  use  of  a  modifier,  primarily 
methanol. To improve the chromatography on certain stationary phases additives have 
been  used.  For  some  compound  types  two  peaks  were  observed  upon  injection,  this 
appears to be linked to compound type and the injection procedure. Data attempting to 
explain  this  phenomenon  is  presented  and  in  particular  how  the  choice  of  injection 
solvent affects possible compound interactions with the stationary phase and peak shape.  
Thus, a direct comparison of HPLC and SFC was  undertaken with a diverse 
series of test compounds using the same conditions, to highlight the effectiveness of the 
two techniques in terms of speed and more importantly compound coverage. HPLC and 
SFC data are presented, comparing a generic analysis protocol with compound specific 
analyses.    Preliminary  findings  showing  the  overlap  between  the  two  separation 
techniques is discussed and specific differences observed with the different column types 
used is outlined  
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Drug discovery in the pharmaceutical industry is a complex and time consuming 
process  involving  hundreds  of  specialists.  Typically,  the  process  of  design, 
synthesis, purification and testing of a drug candidate takes up to 10 to 15 years; a 
typical process cycle is shown in Figure 1.1. It is often a target-driven process, 
where the selected target is disease-relevant and, furthermore, suitable for drug 
development.  Hence,  along  with  the  design  and  synthesis  of  molecules, 
identification,  accurate  and  precise  quantification  at  low  levels  also  plays  an 
important role in this industry. The accurate analysis of the drugs synthesised can 




 Figure 1.1: Drug-discovery timeline.
1 
 
Any time gained by faster analysis is crucial to the drug discovery process as it 
speeds the process of getting the drug to market. The success of achieving the 
final product is also linked to the accuracy of the analysis. Therefore, to avoid 
duplicating the analytical processes, it is important to be able to decide on the 
suitable  technique,  e.g.  High  Performance  Liquid  Chromatography  or 
Supercritical Fluid Chromatography, for separation and identification of the target 
molecule. New drugs are generally more potent than earlier  generations. As a   2 
result the therapeutic dose is less and there is the requirement to detect smaller 
amounts of material. Thus, analytical techniques with low limits of detection are 
necessary.  Further enantiometric purity is a requirement for many modern drugs 
as seen from the example of thalidomide drug which is discussed below. 
The  development  of  analytical  methods  that  can  separate  and  quantify 
enantiomers  has  gained  more  importance,  since  it  became  evident  that 
enantiomers of pharmaceutical products may display different pharmacological 
behaviours;  and  that  the  desired  biological  activity  of  enantiomers  is  mostly 
restricted  to  one  of  the  enantiomeric  structures.  Also  the  US  Food  and  Drug 
Administration  (FDA)  have  set  more  stringent  guidelines  for  marketing  chiral 
drugs. Often, one of the enantiomers is biologically active (eutomer) and the other 
(distomer) may exhibit unexpected adverse reactions, antagonistic activities, or 
toxic effects.
2 Thalidomide is one such known example from the past. The drug 
was marketed as a sedative with few side effects. It was also recommended as a 
remedy for morning sickness for pregnant women in the 1950s and early 1960s. 
Later  it  was  discovered  that  thalidomide  exists  as  two  optical  isomers.  One 
enantiomer was effective against morning sickness and the other was teratogenic 
and caused birth defects. In the 1960s the effect of the drug on some of the painful 
symptoms of leprosy was discovered. In the 1980s, scientists once again became 
interested in the drug's complex properties and researchers began to explore its 
use in the treatment of a number of diseases, including cancer. Trials began in the 
1990s and are now ongoing. It is now known that even when a stereoselective 
sample of thalidomide (only one of the optical isomers) is created, if administered, 
the pH in the body can cause racemisation. Thalidomide is now FDA approved 
drug for the treatment of leprosy and malignancy. But it is prescribed and received 
under strict and special process to avoid anymore children born with birth defects 
from the medication. 
Other techniques such as ultra high performance liquid chromatography (U-HPLC 
or UPLC) have also been introduced as faster and robust analytical techniques. 
Since these are not easily scalable for preparative separations preparative SFC 
(Prep-SFC) is preferred. Prep-SFC was first introduced by Klesper et al.
3, where 
they  mentioned  the  possibility  to  collect  the  separated  compounds,  but  the   3 
progress in development only started after Perrut
4 patented the large scale Prep-
SFC. Some properties of supercritical fluids are particularly favourable for their 
use  in  Prep-SFC.  These  have  good  solvent  properties,  low  viscosity  and  high 
diffusion coefficients and easy modulation of solvent properties by temperature 




The term ‘Chromatography’ covers a wide range of laboratory techniques used to 
separate sample mixtures into their individual components. Simply, it involves 
passing a mixture, dissolved in a "mobile phase" (which may be a gas, a liquid or 
a  supercritical  fluid)  through  a  stationary  phase,  which  can  separate  the 
compounds in the mixture and allow them to be isolated. It is known to be an 
important method for isolating and purifying compounds in the pharmaceutical 
industry. Chromatography was first mentioned by the Russian botanist Twsett, 
often referred to as the father of chromatography, in 1906. His work described the 
separation  of  plant  pigments  using  column  liquid  chromatography.
5  Further 
developments in this field led to planar chromatography using paper as a plane 
support. This was soon superseded by thin layer chromatography (TLC). TLC is 
similar to paper chromatography except the plane stationary phase is a thin layer 
of adsorbent like silica gel on a flat, inert substrate instead of paper. Compared to 
paper,  TLC  has  the  advantage  of  better  separations,  and  the  choice  between 
different adsorbents. Alongside, column chromatography was also developed with 
the introduction of liquid-liquid or partition chromatography. The accompanying 
theory came to be known as the plate theory.
6 Figure 1.2 given below is used to 
explain the terms used in chromatography.   4 
 




The retention times are as follows, 
t0 is the dead time of the column, 
tR1 and tR2 are the retention times of analytes 1 and 2, 
t′R1 and t’R2 are the net retention times of analytes 1 and 2. 
The peak widths are as follows, 
w is the peak width measured at the base of the peak, 
w1/2 is the peak width measured at half the peak height, 
A is distance from the peak front to peak maximum at 10% of peak height, 
B is distance from the peak maximum to peak end 10% of peak height, 
 
Asymmetry, number of theoretical plates, HETP and resolution can be calculated 
from the above terms. Asymmetry (As) is the deviation from an ideal Gaussian 
peak shape. For a peak to be symmetrical the asymmetry factor should be as close 
to 1 as possible. This is calculated as follows, 
A
B
As =           (1.1) 
Resolution  (R)  is  the  measure  of  separation  of  peaks.  Resolution  of  the  two 










=           (1.2) 
In  the  separation  processes,  the  mobile  phase  is  continually  flowing  past  the 
stationary phase; hence the solute does not spend sufficient time in the column for   5 
equilibrium  to  be  achieved.  Therefore  the  column  is  divided  into  number  of 
theoretical  plates  or  cells  of  fixed  height  or  length  that  will  allow  sufficient 
theoretical dwell time for the solute to equilibrate. The faster the equilibrium takes 
place the smaller will be the theoretical plates. Hence there will be more number 
of plates in a column. Thus the efficiency of the column depends on the number of 
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The height equivalent to a theoretical plate (HETP) (h) is the length in which the 
chromatographic equilibrium between mobile and stationary phase is established. 
Since n needs to be large, h should be as small as possible. The value of h is a 
criterion for the quality of the column. The h values depend on the particle size, 
the flow velocity, the mobile phase (viscosity) and especially on the quality of 
packing. The h value is calculated as follows, 
N
L
h =             (1.4) 
where L is the length of the column. 
 
Development  of  gas  chromatography  (GC)  followed  in  the  1950s.  Modern 
capillary GC gives good separation and narrow peaks due to rapid diffusion of the 
molecules in the gas phase. However, it is unsuitable for the analysis of thermally 
labile and non-volatile compounds. To achieve efficiency comparable to GC, high 
pressure was required for the LC column and thus HPLC originated describing 
high pressure LC which produced high performance separations.
6 Hence the term 
high  performance  liquid  chromatography  (HPLC)  is  also  used.  The  most 
commonly used techniques in the pharmaceutical industry are HPLC and GC. The 
former  can  be  readily  used  to  analyze  thermally  labile  compounds,  but  the 
separation is much less efficient because the diffusion is less in liquids than in 
gas.  
 
HPLC is still the most widely used technique in the pharmaceutical industry. But, 
in order to achieve greater speed and accuracy in separation, further developments   6 
have led to new techniques, namely ultra high pressure liquid chromatography 
(UHPLC) and supercritical fluid chromatography (SFC). SFC can be considered 
as a hybrid of gas and liquid chromatography. The difference between SFC and 
the other two methods is that SFC uses supercritical fluid as the mobile phase.  
 
A supercritical fluid can be defined with the help of a phase diagram (Figure 1.3). 
Every substance above a certain temperature can no longer exist as a liquid no 
matter how much pressure is applied; likewise there is a pressure above which it 
can no longer exist as a gas no matter how high the temperature. These conditions 
are called the supercritical temperature and supercritical pressure respectively and 
are the defining boundaries on a phase diagram for a pure substance. A pure 
substance is considered to be in a supercritical state when its temperature and 
pressure are higher than its critical temperatures and pressures respectively. 
 
Figure 1.3: Phase diagram of a pure substance. 
 
Supercritical fluids have good solvating properties and high diffusivity.
8 These 
properties of the supercritical fluid can make SFC up to ten times faster than 
HPLC,  which  is  valuable  for  high  throughput  screening.
9  One  of  the  most 
attractive  features  of  SFC  is  the  speed  of  method  development.  Column 
equilibration occurs much quicker for SFC compared with HPLC, and higher flow 
rates  can  be  used  without  seriously  compromising  efficiency.
10  Most 















   7 
maintaining  equipment,  solvent  usage,  and  disposal  of  waste.  Increased 
production and improved safety are the other requirements of these industries. The 
benefit of SFC is that it can be thought of as a subset of LC, utilizing similar 
equipments and methodologies. SFC has other advantages that are valuable to the 
pharmaceutical industry. Some of the advantages of SFC are fast/shorter method 
development analysis run times, higher efficiency and fast separations with high 
resolutions,  rapid  equilibration  and  high  diffusivity  rates  resulting  in  faster 
column equilibrium. These properties of SFC lead to reduced cycle times along 
with minimal solvent waste, which is of importance in preparative SFC. This in 
turn results in fast sample recovery. It is also a financially less expensive and 
greener technology. SFC is becoming very popular in drug discovery due to the 
speed  with  which  separations  can  be  achieved.  SFC  has  gained  importance 
because it can analyse thermally labile and non-volatile compounds, not amenable 
to GC and with greater efficiency and detector compatibility than HPLC. 
 
1.1  Mobile Phases for SFC 
 
The use of supercritical fluid as the mobile phase in chromatography was first 
published  in  1962  by  Klesper  et  al.
11  In  that  study  supercritical 
dichlorodifluoromethane  and  monochlorodifluoromethane  were  used  as  mobile 
phases to separate nickel etiporphyrin II from nickel mesoporphorin IX dimethyl 
ester. For a fluid to be an effective chromatographic mobile phase the solute must 
be soluble in it. Sie et al. extended the work on SFC to more polar solutes using 
iospropanol  and  Giddings  used  carbon  dioxide.  There  are  number  of  possible 
fluids  that  may  be  used  in  SFC  as  the  mobile  phase.  Hydrofluorocarbons, 
supercritical ammonia, 
12-14 sulfur dioxide and nitrous oxide have also been used 
as mobile phases. Although sulfur dioxide is polar, it is too corrosive. Due to 
general  lack  of  success  and  safety  reasons  carbon  dioxide  (CO2)  has  been  a 
standard  choice  of  the  mobile  phase.  CO2  has  low  interference  with 
chromatographic techniques and suitable physical properties (non-flammable, low 
critical values) and low cost.
15 The critical temperature of CO2 is 31°C and the 
critical pressure is 72 bar.
16 Supercritical CO2 is a fluid with a polarity comparable 
to that of n-heptane. It is known from the supercritical fluid extraction processes, 
increasing  the  pressure  increases  the  dissolving  power  of  the  fluid.  Many   8 
substances with single polar functional groups, e.g. formic acid, phenol, aniline 
are soluble in CO2.
17 However, more complex, polyfunctional solutes tend to be 
much less soluble. These solutes are less likely to be eluted with CO2. The only 
disadvantage of using CO2 as mobile phase is its inability to elute very polar or 
ionic  compounds.  However  this  can  often  be  overcome  by  addition  of  small 
amounts  of  a  second  liquid  known  as  a  modifier.  Advantages  of  the  use  of 
supercritical CO2 are that the cost for the disposal of solvent is reduced, and also it 
is easier to recover the compounds from it. This can be viewed as increasingly 
important to industries.  
 
A modifier is generally an organic solvent that is completely miscible with CO2 
but can be any liquid including water. Up until the late 1980s it was believed that 
the addition of modifiers did not increase the polarity of carbon dioxide. Changes 
in retention were attributed to changes in the density of the fluid.
5 It is now known 
that polar solvents cause significant changes in retention of polar solutes, and that 
changes in the density of binary fluids cause smaller shifts in retention.
6 Ethanol, 
methanol, isopropanol, dichloromethane, tetrahydrofuran (THF), and acetonitrile 
are some of the examples of modifiers that have been used in SFC. However, 
methanol has been the most widely used. The addition of a modifier improves the 
solvent strength of the supercritical fluid and sometimes changes the selectivity of 
separation. It may also help improve separation efficiency by blocking some of 
the highly active sites on the stationary phase.
18 Systematic studies of the effect of 
modifiers on the retention of polar solutes using modified carbon dioxide and 
packed columns have been published.
19-21   
 
The use of modifier alone may not be sufficient to elute strong acids and bases. 
Hence  further  addition  of  organic  acids  and  bases  such  as  trifluoroacetic  acid 
(TFA)  and  dimethylethylamine  (DMEA)  may  be  required  to  optimise  the 
chromatography. These are called additives. The first use of additives to SFC 
eluent was reported in 1988.
22 Most strong organic bases do not elute or elute with 
poor peak shapes from packed columns such as –CN columns using pure CO2. 
Addition of methanol caused the solutes to elute but with very poor peak shapes. 
The  addition  of  basic  additive  to  the  mobile  phase  resulted  in  a  dramatic 
improvement in peak shapes.
20 Most polyfunctional organic acids and hydroxy   9 
acids  do  not  elute  or  elute  with  poor  peak  shapes  using  packed  columns  and 
methanol  modified  CO2.  Numerous  papers  have  been  published  studying  the 
effectiveness  of  various  additives  in  improving  the  peak  shapes  of  acidic 
solutes.
23-26  In  general,  stronger  acids  make  the  best  additives  for  suppressing 
tailing and improving peak shapes of acidic solutes. J. Zheng et al. established 
that cationic amine salts can be separated by SFC using an ionic additive in a 
methanol  modified  CO2  mobile  phase.  An  ion-pairing  interaction  between  the 
positively  charged  analytes  and  the  anionic  part  of  the  sulfonate  additive  was 
suggested.
27 The effects of modifiers and additives also depend on the type of 
stationary phase used.  
1.2  Stationary Phases for SFC 
 
A wide range of achiral and chiral stationary phases (CSP) can be used in SFC, 
most of which are silica-based, though polysaccharide-, zirconia-, polystyrene-, 
divinylbenzene
28,29 and porous graphitic  carbon
30 based packing materials also 
exist. A number of these packing materials were first designed for HPLC, such as 
polysaccaride-based  CSP  Chiralcel  OD  (cellulose  tris[3,5-dimethyl- 
phenylcarbamate]), Chiralcel OJ (cellulose tris[4-methylbenzoate]) and Chiralpak 
AD (amylose tris[3,5-dimethylphenylcarbamate]), which are all efficient in both 
SFC
2,31 and HPLC.
32 Structures of the stationary phases are shown in Figure 1.4. 
 
 
Figure 1.4: Structure of polysaccaride-based chiral stationary phases.
2 
 
   10 
In a chiral column, achiral silica gel (SiO2) is converted into chiral stationary 
phase by a reaction with chiral molecule. As the mixture of enantiomers move 
along the column one enantiomer attaches to the stationary phase better than the 
other  thus  resulting  in  separation.  There  is  a  three  point  interaction  with  the 
carbonyl group aligning with the amino groups and the aromatic lining up with 
each other to form π-stacking interactions. The other enantiomer will not be able 
to have  all three interactions because its  groups are not  aligned correctly  and 
hence cannot associate itself to the stationary phase, thus eluting first.  
 
Achiral SFC applications typically use polar stationary phases such as bare silica, 
amino and diol phases shown in Figure 1.5. Although these phases are adequate 
for many applications, there is still a need for additional polar phases. As a result, 
a series of amide, urea and pyridine phases have been developed to enhance the 
capability of SFC. Using spherical silica as the packing material provides low 
surface areas and therefore is beneficial for separations requiring low percentages 
of  organic  modifiers.  Higher  column  efficiencies  are  obtained  with  spherical 
particles than with irregular particles because spherical particles can form more 
tightly packed beds thereby reducing the column void volume. Smaller particles 
offer more efficiency but produce higher back pressures. The amount of surface 
area,  usually  quoted  in  metres  squared,  which  is  available  for  bonding,  and 
therefore available for analyte retention, is dependent on pore size. A larger pore 
size means bigger holes in the particle, leaving less surface area than would be the 
case with smaller holes. The higher the surface area, the higher is the carbon-load.  




















Figure 1.5: Structures of achiral stationary phases. 
 
1.3  Instrumentation for SFC  
 
Over  several  decades,  inadequate  instrumentation  caused  a  number  of 
misinterpretations and false directions in the development of SFC. A supercritical 
fluid chromatograph simply consists of a mobile phase container, an injector, a 
column contained in an oven, a restrictor and a detector. The mobile phase is 
initially pumped as a liquid and is brought into the supercritical phase by heating 
it above its supercritical temperature before it enters the chromatography column. 
The mobile phase is mixed in a mixing chamber, and then passes through an 
injection valve where the sample is introduced into the supercritical stream and 
then into the column. It is maintained supercritical as it passes through the column 
and into the detector by a pressure restrictor placed either at the end of the column 
or  after  the  detector.  Often  the  restrictor  must  be  heated  to  prevent  sample 
clogging. Figure 1.6 shows a typical instrumental set-up for SFC. Some of the 
components involved have been discussed briefly in this chapter. 
 
   12 
 
Figure 1.6: A typical SFC instrument.  
 
1.3.1  Pumps for SFC 
 
During the 1980s most SFC systems used syringe pumps, operated as pressure 
sources. Flow was passively controlled with a fixed restrictor mounted on the end 
of the column. The problem with this type of arrangement was the inability to 
control individual parameters, such as flow rate, solvent density, temperature and 
composition, and determining the effect of any one variable on retention.
17, 33 The 
use  of  syringe  pumps  with  binary  fluids,  premixed  binary  mixtures  were 
developed by gas supply companies. It is now known that the composition of the 
fluid withdrawn from premixed cylinder changes as the cylinder is used up. The 
MeOH-CO2 composition delivered from a premixed cylinder changes by a factor 
of  two  from  the  first  to  the  last  use.  As  retention  is  approximately  inversely 
proportional  to  methanol  concentration,  doubling  the  concentration  halves  the 
retention.
34, 35  
 
From 1979 to 1983, a group at Hewlett-Packard used a modified HPLC with two 
high pressure reciprocating pumps operated as flow sources. One pump delivered 
compressed fluid whilst the other was used to pump modifiers. A mechanical back 
pressure regulator controlled downstream pressure. Thus at different pressures and 
flows  the  combined  pumps  delivered  different  compositions,  although  the 
























Mixer   13 
in  Basel  published  instrument  details  in  1980.
36-39  Modern  packed  column 
instruments  use  multiple  high  pressure  reciprocating  pumps  operated  as  flow 
sources.  The  system  pressure  is  independently  controlled  through  the  use  of 
electronic  back  pressure  regulators.  Such  a  configuration  allows  accurate 
reproducible  composition  programming  while  retaining  flow,  pressure  and 
temperature control.
5 
1.3.2  Columns for SFC 
 
SFC  has  a  wide  range  of  capillary  and  packed  columns  suitable  for  analysis. 
Although special columns for SFC are now available, both normal and reversed 
phase  HPLC  columns  can  be  used  in  SFC.  Around  1980s  Hewlett  Packard 
introduced the instrument for packed column SFC. However, capillary columns 
were more popular during the time.  Capillary columns are open tubular columns 
of narrow internal diameter made of fused silica with the stationary phase bonded 
to  the  wall  of  the  column.  These  types  of  columns  are  most  suited  for  high 
efficiency separations and complex samples. Packed columns emerged once again 
in the 1990’s emphasising on more polar solutes from the pharmaceutical and 
agrochemical industries. The packed columns contain small, deactivated particles 
to which the stationary phase is chemically bound. The packed columns are useful 
for high speed separations requiring moderate column efficiency and for samples 
containing fewer components. Figure 1.7 shows the cross sections of both packed 
and capillary columns. The tubing for the packed columns is conventionally made 
of stainless steel. A third type of column called packed capillary columns show 
higher sample capacity and shorter analysis time in comparison to open-tubular 
capillary columns. 
 










      (1.5)   14 
Figure 1.7: Column cross section of packed and capillary columns
15. 
 
Typically,  packed  columns  are  10  to  100  times  more  retentive  than  capillary 
columns as a result of their greater phase ratio.
41 The reason packed columns often 
require a modified mobile phase is due to their greater retention capacity. In an 
effort to retain the use of pure carbon dioxide, there have been attempts to either 
deactivate silica based packing materials or use polymer based packing.  
 
1.3.3  Detectors for SFC 
 
Chromatography is an important analytical technique which when equipped with 
sensitive  detectors,  is  capable  of  performing  qualitative  and  highly  accurate 
quantitative analysis. The ultra-violet (UV) absorbance detector is by far the most 
popular LC detector which is currently available to the analyst. This is particularly 
true if multi-wavelength technology is included in this class of detectors. Its use is 
limited mainly because it does not give a uniform response to different analytes, 
i.e. it is not a universal detector.  Although the UV detector has some definite 
limitations (particularly for the detection of non polar solutes that do not possess 
UV chromophores) it has the best combination of sensitivity, linearity, versatility 
and reliability of all the LC detectors developed until now. The refractive index 
(RI) detector is universal, but it is not as sensitive or stable and cannot be used 
with gradient elution. Mass spectrometry is now a popular LC detector.  
SFC  has  the  advantage  of  compatibility  with  both  HPLC  and  GC  detectors. 
However, it is important to consider the mobile phase composition, column type 
 
Packed 
Capillary   15 
and flow rate when selecting a detector for SFC. This is because for e.g. SFC 
polar modifiers will produce high background noise for flame ionisation detectors 
(FIDs),  and  certain  detector  components  may  not  be  compatible  for  the  high 
pressures  used  in  SFC.  Some  of  the  detectors  interfaced  with  SFC  are  mass 
spectrometers,  flame  ionisation  (FID),  electron  capture,  evaporative  light 
scattering (ELSD), nitrogen-phosphorus, and phosphorus sensitive detectors. In 
all,  these  detectors  give  a  wide  variety  of  sensitive  selectivity.  The  practical 
universal detector of choice is MS as it provides structural information about the 
eluted compounds. When using capillary columns and CO2 mobile phase, all GC 
detectors  and  many  HPLC  detectors  can  be  used.  The  major  advantage  of 
capillary  column  SFC  over  HPLC  is  its  compatibility  with  the  FID.  The 
combination of packed column SFC with MS or FID often requires splitting of the 
eluent from the SFC.   
The most common detector used with SFC is the ultra-violet (UV) absorbance 
detector. In order to operate under high pressures, the flow cell in an UV detector 
needs  modification.  Most  of  the  publications  describing  detection  are  that  of 
spectroscopic and spectrometric detectors, which provide structural information 
about the eluted analytes. Harrasch and co workers showed that APCI was found 
to  be  superior  to  electrospray  ionisation  for  the  analysis  of  a  mixture  of  four 
hydroxysteroids.
9  Garzotti  and  co-workers  have  described  a  novel  feature  of 
combining  an  ESI  ion  source  with  a  TOF  analyser  without  the  need  for  an 
interface between the source and the SFC system which provided accurate mass 
positive ion electrospray mass spectra for a number of compounds.
2 In this project 
UV and MS were used as detectors and these will be discussed. 
 
Ultra-violet detectors  
 
There are two factors that control the detector sensitivity, the magnitude of the 
extinction  coefficient  of  the  solute  being  detected  (which  will  depend  on  the 
wavelength of the UV light which is used and on the compound structure) and the 
path  length  of  the  light  passing  through  the  cell.  It  follows  that  the  optimum 
detector cell design involves the determination of the cell length that will provide 
the maximum sensitivity and at the same time constrain detector dispersion to a   16 
minimum so that there is minimum loss in resolution. There are three types of UV 
detectors. Fixed wavelength is the simplest version of UV detectors. It employs a 
UV light source, typically a low pressure mercury vapour lamp which provides 
several  distinct  lines  of  UV  radiation  with  254  nm  being  most  intense.  The 
radiation is then passed through a filter to remove other wavelength light. Due to 
the fact that not all compounds absorb at 254 nm variable wavelength detectors 
are used to allow the user, the option of choosing an appropriate wavelength. This 
was accomplished by adding a monochrometer.  A deuterium lamp provides a 
continuous sequence of UV radiation producing a broad band of radiation from 
190 up to 800 nm. This light is then separated into its component wavelengths by 
using a grating which is placed on a moveable platform. This allows the user to 
choose any wavelength from the spectrum at any one time. The photodiode array 
detectors are one step further than the variable wavelength detector as it allows 
the  user  to  access  all  of  the  wavelengths  simultaneously.  Like  in  a  variable 
wavelength detector, a continuum source is used and the entire spectrum of light 
is passed through the detector cell. A single detector is replaced by a multiple 
array of individual detectors called photodiodes. These are arranged on a single 
chip called the photodiode array. In this project a variable wavelength detector 
was used with the SFC instrument. 
 
In recent years mass spectrometers have become increasingly popular as detectors 
for chromatographic systems. HPLC-MS is a commonly used technique in the 
pharmaceutical and other chemical industries. The coupling of HPLC to MS used 
to be a difficult process due to the transition of liquid phase ions at atmospheric 
pressure  to  gas  phase  ions  in  a  vacuum.  The  difficulties  involved  introducing 
solutions to the vacuum system of the mass spectrometer. One solution is to apply 
heat to aid evaporation, but this can lead to the thermal degradation of the analyte. 
One other issue is the capacity of vacuum pumps to deal with a large gas load i.e. 
1 mL of solvent creating approximately 1 L of vapour. In order to couple a liquid 
chromatograph to a mass spectrometer, the system must be capable of evaporating 
liquids into gases, be able to ionise the species present and be able to remove the 
large amounts of solvent whilst maintaining the required vacuum for the mass 
analysers. Early examples of LC-MS interfaces used were the moving belt, fast 
atom  bombardment  (FAB),
42  thermospray  (TSP)
43  and  particle  beam  (PB).
44   17 
These  were  subsequently  followed  in  the  late  1980s  by  atmospheric  pressure 
ionisation (API) techniques; electrospray ionisation (ESI), atmospheric pressure 
chemical  ionisation  (APCI)  and  atmospheric  pressure  photoionisation  (APPI). 
These  interfaces  simplified  the  coupling  of  HPLC  to  MS  and  are  the  most 
commonly used systems today.
45 
 
Supercritical  fluid  chromatography-mass  spectrometry  (SFC-MS)  is  fast 
becoming a recognised technique due to the growing need for high speed and high 
quality separations.
46 The interest in using MS with SFC has increased in the last 
decade following the advent of the atmospheric pressure ionisation sources.
47 SFC 
coupled with MS forms a more selective and informative technique when dealing 
with  mixtures  containing  unknown  compounds  or  those  with  poor  UV 
absorption.
48  In  most  cases  MS  provides  target  compound  detection,  good 
sensitivity  and  in  some  cases  structural  information  for  identification  of  the 
unknown compounds. When SFC is interfaced with a mass sensitive detection, a 
powerful analytical tool for the analysis of difficult mixtures can be realised.
44  
The  key  advantage  of  SFC  is  minimal  solvent  waste,  which  is  particularly 
important in preparative SFC, leading to fast sample recovery. The coupling of 
SFC  to  MS  was  first  reported  by  Randall  and  Wahrhaftig  in  1978  using  a 
molecular  beam  interface.
49  This  realised  a  powerful  analytical  tool  for  the 
analysis  of  complex  mixtures.
44    As  mentioned  above,  CO2  has  become  the 
standard choice of the mobile phase. Other advantages of CO2 are its low cost, 
low  carbon  footprint  low  interference  with  chromatographic  techniques  and 
suitable  physical  properties  (non-toxic,  non-flammable,  low  critical  values). 
Under supercritical conditions, CO2 has the advantage of low viscosity, which 
allows a high flow rate without over-pressuring the system. Also, mass transfer is 
very high, thus improving column efficiency. When combined with MS, the CO2 
is more readily handled by the vacuum system due to its high volatility, and can 
enhance volatilisation at the inlet to the mass analyser. Several types of interface 
have been reported in the literature, some being modified from LC-MS systems, 
and some being specially developed for SFC-MS. The ionisation techniques used 




51 and more recently ESI.
52 
A  novel  arrangement  in  which  SFC  was  directly  coupled  to  a  hybrid  mass   18 
spectrometer  (Q-Tof 2)  was reported; this provided accurate mass positive ion 
electrospray mass spectra for a number of compounds.
2, 8  
 
Quadrupole Mass Spectrometer 
 
Quadrupole mass analysers are widely used in various areas of chemical analysis. 
In a quadrupole mass analyser the ions are separated on the basis of their mass to 
charge ratio. Only ions within a narrow mass region are allowed to pass through 
the device. The resolving properties of quadrupole result from an ionic intrinsic 
stability or instability within the device. The distance between the ion source and 
detector  is  about  15cms.  The  short  distance  combined  with  strong  focussing 
properties  makes  the  quadrupole  analyser  useful  at  high  pressures  and  the 
capability of fast scanning, thus making it useful to be combined with GC and LC. 
Another feature of the quadrupole mass analyser is that it is mechanically simple, 




A quadrupole consists of two pairs of metallic rods (Figure 1.8). The four rods are 
equidistant from the central axis. The adjacent rods have opposite potential. A 
combination of DC and RF voltages are applied to the rods. Each rod pair is 
successively positive and negative allowing ions to be both attracted and repelled 
from the central axis. A potential difference is applied at the entrance and exit of 
the quadrupole. This pushes the ions out of the quadrupole. Ions that undergo 
stable  oscillations  are  separated  according  to  their  mass  to  charge  ratio. 
Depending on the magnitude of the voltages only ions of certain mass are allowed 
to be detected. Other ions are deflected causing them to collide with the rods and 
then pass out of the analysing device. 
   19 
 
Figure 1.8: Schematic diagram of quadrupole mass spectrometer.
54 
 
1.4   Theory and coupling with SFC 
 
Here in this project, a Berger Minigram SFC was coupled to a Platform LCZ. The 
Berger Minigram operates with the SFC Pronto software. A photograph of the 
SFC-MS set-up is shown in Figure 1.9. Further discussion on the system will be 
given in Chapter 2.  
 
The SFC was interfaced with the MS by using of two Valco stainless steel T-
pieces and a length of PEEK tubing (0.0025 inch I.D.) between the UV and MS. 
The first T-piece was inserted after the UV detector output and before the back 
pressure regulator. The other end of the PEEK tubing was connected at the second 
T- piece leading to the MS. The third arm of the second T-piece was connected to 
a make-up solvent pump. A Hewlett Packard HPLC pump was used as a make-up 
pump to deliver 0.1 mL min
-1 of methanol. This post column modifier is essential 
for  two  reasons.  Firstly,  as  CO2  is  not  known  to  produce  ions  under  any 
investigated  conditions  nor  does  it  plays  a  direct  role  in  ion  formation,  it  is 
essential to add post column modifiers for example methanol into the CO2 stream 
to aid generation of ions in the mass spectrometer. Secondly, adding a make-up 
fluid prevents the precipitation of solutes in the tubing.
16, 48 
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Figure 1.9: Photograph of the SFC-MS set-up showing the interface between SFC 
and MS. 
 
Electrospray ionisation (ESI) 
 
Electrospray ionisation is essentially a solution phase process. Electrospray takes 
place as a result of a strong electrical charge applied to the eluent as it emerges 
from the capillary. The sample is introduced in solution phase through a capillary 
tube to the end of which high electric field is applied. The solution is nebulised to 
form  a  spray  of  small  droplets.  Frequently,  the  sample  nebulisation  and 
subsequent droplet evaporation is assisted by the co-axial flow of warm nitrogen 
gas, i.e. pneumatically-assisted electrospray ionisation. This can be enhanced by 
introducing  a  gas  near  the  end  of  the  charged  capillary.  The  spray  from  the 
capillary reaches strong electrostatic field at atmospheric pressure which results in 
production of fine aerosol of highly charged droplets. Evaporation of solvent from 
these droplets and droplet disintegration results in formation of ions. Ions may be 
singly or multiply charged (Figure 1.10). 
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The  ionisation  of  the  species  follows  one  of  the  two  paths  depending  on  the 
polarity of the charge applied to the capillary 
 
M + X￿ [M + nX]
n+ 
M - X￿ [M - nX]
n- 






Figure 1.10: Diagram of electrospray ionisation source. (Modified from reference 
55) 
 
The source is simple in design and robust. Protonated or deprotonated molecules 
are  produced  depending  upon  the  characteristics  of  the  analyte  and  chosen 
polarity of mass spectral analysis. These characteristics have led to ESI being the 
most commonly used ionisation technique in the pharmaceutical industry.  
 
Although a definitive mechanism for production of gas phase ions in ESI is not 
known, two models have been suggested (shown in Figure 1.11). Iribarne and 
Thompson
43,  56  put  forward  the  ion  evaporation  model  (IEM)  where  a  single 
solvated analyte ion carrying some of the droplets charge is desorbed into the gas 
phase. This mechanism is said to be dominant for small molecules as these can be 
easily separated from the solvent molecules. The other mechanism is the charge 
residue  model  (CRM)  proposed  by  Dole  and  co-workers.
57  This  suggests  that 
continuous evaporation and fission of the charged droplet occurs until it contains 
only one analyte molecule. The charge then transfers to the analyte. This model is 
said to be applicable when the solute molecule has linear dimensions significantly 
larger than the charged droplet that contains it. Hence it is proposed that gas phase 
ions of macromolecules are formed in this manner.
57, 58 




Figure 1.11: Schematic showing the (a) charged residue model and (b) ion 




Atmospheric pressure chemical ionisation (APCI) 
 
ESI  and  APCI  are  complementary  techniques.  APCI  generally  produces 
protonated or deprotonated molecular ions from the sample via a proton transfer 
(positive  ion)  or  proton  abstraction  (negative  ion)  mechanism.  The  sample 
solution is vaporised in a heated chamber before entering the plasma consisting of 
solvent ions formed by a corona discharge within the atmospheric pressure ion 
source. The solvent vapour is then ionized by the electric field, either by removal 
(positive ion mode) or donation (negative ion mode) of an electron, which then 
results  in  the  formation  of  reactive  species.  Ionisation  occurs  as  a  result  of 
chemical  reactions  between  the  sample  molecules  and  plasma  ions.  Proton 
transfer  takes  place  between  the  solvent  ions  and  the  sample.  For  e.g.  here 
methanol is present in the mobile phase. 
 
Positive ion mode 
MeOH              MeOH             MeOH2  +  MeO 
 
Negative ion mode 
MeOH              MeOH             MeO  +  MeO  +  H2 
 
+ •  +   • 
_ • 
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As the sample enters the plasma it then reacts with the reactive species to give 
protonated or deprotonated molecule. 
 
Positive ion APCI follows 
Proton transfer: MeOH2 + M ￿ [M + H]
+ + MeOH 
 
Negative ion APCI follows 
Proton abstraction: MeO + M ￿ [M - H]
- + MeOH 
 
   
Figure 1.12: Diagram of APCI source. (Modified from reference
60) 
 
APCI is a gas phase ionisation process. Thus the analyte must be stable in the gas 
phase. In APCI the sample solution is injected into a heated fused silica capillary 
which behaves as a vaporiser. The vaporisation is assisted by a nitrogen flow 
coaxial to the capillary (Figure 1.12). The analyte then ionises as it approaches the 
corona discharge needle. Solvent evaporation occurs first and then the ions are 
formed. The analyte is nebulised to very small droplets by evaporation of solvent 
using a very hot auxiliary gas. One of the problems experienced initially was the 
presence of still solvated analyte molecules i.e. the presence of clusters of analyte 
molecules with different numbers of solvent molecules. To obtain a de-clustering 
of  these  species  different  approaches  have  been  proposed,  among  which  non-
reactive collisions with target gases and thermal treatments are those considered 
most  effective  and  currently  employed.  In  the  case  of  quantitative  analysis, 
particular  care  must  be  devoted  to  finding  the  best  operating  conditions  for 
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in achieving stable signals. Formation of the charged molecular species are based 
on the production of acidic or basic species in the gas phase which further react 
with  a  neutral  molecule  of  analyte  leading  to  [M  +  H]
+  or    [M  -  H]
-  ions, 
respectively. 
 
Thermospray ionisation (TSP) 
 
In  thermospray  the  chromatographic  eluent  is  rapidly  heated  and  the  spray  is 
formed under vacuum. The solution passes through the vacuum chamber as a 
supersonic beam. A fine droplet spray is generated which contains analyte and 
solvent  molecules  as  well  as  ions.  The  ions  in  solution  are  extracted  and 
accelerated  towards  the  analyzer  by  a  repeller  electrode  and  a  lens  focusing 
system. The ions are desorbed from the droplets carrying one or several solvent 
molecules or dissolved compounds. Ions go directly from the liquid phase to the 
gas phase. To improve the ion extraction the droplets at the outlet of the capillary 
may be charged by a corona discharge, i.e. plasmaspray. The droplets stay on their 
supersonic path to the outlet, where they are pumped out continuously through an 
opening located in front of the supersonic beam. Large vapour volumes are thus 
avoided. In order to avoid freezing of the droplets under vacuum, the liquid must 
be heated during injection. Addition of a volatile buffer, e.g. ammonium acetate, 
enhances the ionisation process due to formation of (M + NH4)
+ ions. Figure 1.13 
shows the TSP source, first introduced by Blakely and Vestal,
43 was one of the 
early interfaces for an  LC-MS system, which  produced ions  from an  aqueous 
solution that had been sprayed directly in the mass spectrometry. Thermospray 
ionisation is achieved by passing a pressurised solution through a heated tube 
which partially vaporises the effluent to generate a spray before entering the ion 
source. The droplets gradually decrease in size by evaporation of neutral solvent 
molecules until the droplet reaches a size at which the charge repulsion forces 
overcome the cohesive forces of the droplet.  
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Figure 1.13: Diagram of thermospray ionisation source.
60  
 
Sonic spray ionisation (SSI) 
 
SSI is a relatively novel API technique first developed by Hirabayashi  and  co-
workers
61 in the 90s. It features an external ion source to a mass spectrometer 
similar to ESI. In this technique the column eluent is sprayed from a fused silica 
capillary with a sonic velocity gas flow co-axial to the capillary resulting in the 
formation of ions and charged droplets under atmospheric pressure. Figure 1.14  
shows the schematic diagram for the sonic spray ionization interface. The ion 
intensity strongly depends on the gas flow velocity.
61 In sonic spray ionisation it is 
not necessary to apply heat or an electric field to the capillary of the ion source. A 
sonic spray ion source consists of two capillaries the inner fused silica capillary 
which introduces the analyte solution and the outer stainless steel capillary that 
provides  a  coaxial  nitrogen  gas  flow  to  facilitate  droplet  nebulisation. 
Subsequently the ions are introduced through a sampling orifice into a vacuum 
region where the mass analysis can be performed. Since SSI is operated in API 
conditions without any electric potential applied, it is considered as a very soft 
ionisation  method.  Thus,  fragmentation  of  analytes  is  minimised  and  the 
technique can be easily applied to thermally labile compounds.
62, 63 The maximum 
number of ions are produced by this method when the nebulisation gas is flowing 
at  sonic  velocity  (gas  velocity  of  Mach  1).  When  voltage  is  applied  in  SSI 
increased ion production and higher charge states are observed similar to that of 
ESI  and  this  is  termed  as  electro-sonic  spray  ionisation  (ESSI).  SSI  requires   26 
higher pressure and flow rates compared to ESI. The conditions of SFC system 
were then studied and, the results are explained in Chapter 2.  
 
 
Figure 1.14: Schematic diagram of the sonic spray interface.
61 
 
An  attempt  to  understand  the  ionisation  mechanism  in  an  SFC-MS  system  is 
shown in Chapter 2. Ionisations of compounds were observed in the absence of 
high voltage on an ESI source. The observations were also compared using an 
APCI source. 
 
1.5  Applications of SFC 
 
SFC is being widely used as a separation technique in several fields. It has been 
applied to a wide variety of materials including natural products, drugs, food, 
pesticides and herbicides, fossil fuels, explosives and propellants.
64  Listed below 
are some of the recent SFC applications areas.
65 
 
1.5.1  Food related applications   
 
Several food related applications of SFC have been mentioned in the reviews
66-69  
and these include analysis of pesticides and their metabolites in food stuffs, fatty 
acids and triacylglycerols and triglycerides etc. For example, SFC analysis was 
used  to  investigate  the  changes  on  heating  of  low-linolenic  soybean  oil  and 
partially hydrogenated soybean oil.
70 Rezaei and Temelli used SFC to monitor the 
products of enzymatic reactions in supercritical CO2.
71 In some other publications   27 
SFC/UV was used to characterise polyphenolic compounds in an SFE extract of 
grape seed.
72 Recently SFC was used to isolate and quantitatively analyse minor 
components from palm oil.
73 Interests in the assessment of antioxidants in food 
have risen considerably. Although HPLC is popular in this field, use of SFC for 




Separation  of  antioxidants  from  rosemary  essential  oils  using  SFC  is  another 
example. In this case an attempt is made to analyse polar compounds without the 
use of added modifier. Columns were specially developed to tune the polarity of 
stationary  phase  by  Ramirez  et  al.  This  would  enable  separation  of  polar 
compounds  using  pure  CO2.  Two  types  of  columns  were  developed,  silica 
particles were coated with either SE (5% penyl, 95% methyl silone) or carbowax 
20M (polyethylene glycol).  Resolution of principal anti oxidant compounds was 
achieved at relatively high pressure and temperature.
75  
 
Han  et  al.  reported  the  separation  of  tocopherols,  vitamin  E  and  similar 
antioxidants  from  palm  oil.
76  I.  Francois  et  al.  have  demonstrated  the  use  of 
multidimensional chromatography for the analysis of fatty acids in fish oil. Silver 
ion SFC (SI-SFC) and RP-LC in first and second dimensions respectively was 
found to have increased orthogonality and peak capacity in comparison to RP-LC 
X 2RP-LC separation of phenacyl esters of fatty acids in fish oil extract. To obtain 
SI-SFC columns, two 25 cm acidic cation exchange columns were loaded with 
silver ions and then rinsed with ammonium acetate solution. The two columns 
were then coupled in series. For the second dimension a 5 cm C18 column was 
used
77. 
1.5.2  Pharmaceuticals 
 
The use of SFC has grown rapidly in the pharmaceutical industry both for chiral 
and achiral analysis. The majority of work in the recent  years involves chiral 
chromatography.  As  a  result  of  the  increase  in  regulatory  scrutiny  of  drugs, 
importance of enantiomer separation has also increased. SFC is also found to be 
useful in screening applications. Along with other techniques, the use of SFC in   28 
the analysis of antibacterial and antirheumatism compounds found in traditional 
herbal medicines was reported by Wen et al.
78 Gyllenhaal showed that both chiral 
and achiral analyses can be performed on the same drug. This was demonstrated 
on a preoxysome proliferation receptor agonist drug. Using SFC both separation 
of enantiomers  and separation of the  active drug from process impurities was 
achieved.
79 
   
 
Achiral and Bioactive Compounds 
 
Bromosulphone, which underwent on-column degradation during reversed-phase 
HPLC  separation,  was  not  only  found  stable  under  SFC  conditions  but  the 
required separation of seven process related impurities from bromosulphone, was 
achieved in 5 minutes.
80 Gyllenhaal and Hulthe reported the direct injection of 
aqueous  sample  solutions  of  isosorbide-5-mononitrate  by  packed  column  SFC 
where Imdur tablets were dissolved in gastric media and directly injected. The 
mobile phase was CO2 modified with 20% 2-propanol and the stationary phase 
was diol functionalized silica.
81 Aqueous injections are generally not used but in 
this application the stationary phase was sufficiently polar to allow such injections 
without significant breakthrough. A few publications discussing the use of SFC, 
supercritical fluid extraction (SFE) and related techniques in medical radioisotope 
processing and chemistry have also been reported.
82, 83  
 
In  another  instance,  Gyllenhaal  and  Karlson  separated  metoprolol,  a  β-
adrenoreceptor blocking drug from related amino alcohols using a porous graphite 
carbon column. Structures of these are shown in Figure 1.15. The analytes are 
structurally related and include impurities and metabolites. The study included 
different  areas  such  as  modifiers,  additives  and  the  influence  of  the  additive 
concentration  and  column  temperature  on  selectivity  and  retention.  To  obtain 
good symmetry of the metoprolol peak at high concentration, 200mM or more, of 
amine additive was used resulting in improved retention and column efficiency. 
The resolution between the meta and para metoprolol was found to vary with 
different mobile phase additives. The order additives was ammonia, followed by   29 
N,N-dimethyloctylamine  and  lastly  triethylamine.  The  effect  of  increasing  the 
concentration of the amine additive on the retention or selectivity was negligible. 
The selectivity of the analytes changed with change in column temperature.  Here 





Figure 1.15: Structures of metoprolol and related amino alcohols.
84 
 
In the area of bioactive compounds, packed column SFC-UV was used for the 
determination of the potential carcinogen benzidine and its acetylated metabolite. 
The authors compared the method to the published HPLC-UV method and found 






The separation of enantiomers is an important area of separation science. The vast 
majority  of  chiral  separations  by  SFC  have  been  performed  using  packed 
columns. Two new high performance amylase chiral columns, Chiralpak AS-H 
and Chiralpak AS-RH were designed to be compatible with SFC.
86 The effects of   30 
two basic additives, isopropylamine and triethylamine, on chiral SFC separations 
using  macrocyclic  glycopeptide  or  derivatised  polysaccharide  columns  are 
reported by Phinney and Sanders where they show that additives were required for 
elution of many of the analytes from the glycopeptide column and increasing the 
additive concentration resulted in a decrease in retention.
87 The additives had little 
effect on retention on the polysaccharide phase but resulted in better peak shapes 
and resolution.  
 
Garzotti and Hamdan used SFC coupled to a hybrid mass spectrometer (Q-Tof2) 
equipped with electrospray ion source to separate and characterise a wide range of 
pharmaceutical racemates. Chiral SFC has been applied to a wide variety of chiral 
compounds, mostly in the analysis of pharmaceuticals. The speed of chiral SFC 
separations was compared to the conventional normal and reverse phase chiral 
HPLC. A comparative study of enantioselective separation of several anti-ulcer 
drugs  using  HPLC  and  SFC  on  a  chiralpak  AD  column  was  carried  out  by 
L. Toribio  et  al.
88  The  results  showed  that  only  two  of  the  compounds, 
omeprazole and pantoprazole, could be resolved using HPLC whilst SFC allowed 
the enantiomeric separation of all four compounds studied with higher resolution 
and  lower  analysis  times.  Later  on  Toribo  also  separated  racemic  antifungal 





1.5.3  Natural Products 
 
SFC was included in reviews of techniques for sesquiterpene  and valepotriate 
analysis.
90 The selectivity of SFE at different pressures was highlighted by Kaplan 
et  al.
91  Chromatographic  resolution  of  the  polyprenols  with  chain  length  and 
geometric  isomer  variations  showed  a  marked  improvement  for  SFC  over 
conventional HPLC separations.
92 SFC was used to elute large peptides (at least 
40mers)  containing  acidic  and  basic  residues.  A  2-EP  column  with  ethanol 
modified  CO2  mobile  phase  and  trifluoroacetic  acid  additive  was  used.
93 
Desmortreux et al. have shown that SFC can remarkably reduce the analysis times   31 
from  45  mins  to  10  mins  for  the  separation  of  furocoumarin  in  essential  oil 
composition. A Discovery HS F5 column was used for the analysis with CO2-
EtOH 91:9 (v/v) modifiers.
94 
1.5.4  Fossil Fuels and Bio Fuels  
 
SFC with UV detection can be used to determine conjugated dienes in petroleum 
products.  The  method  used  two  coupled  silica  columns  and  pure  CO2  as  the 
mobile phase.
95 Using SFC and two-dimensional SFC  Lavison et al. analysed 
polar  car  lubricants.  The  specific  detectors  used  were  AED,  FTIR  or  MS.
96 
Further a hyphenation of SFC to APCI-MS is described for the analysis of polar 
car  lubricant  additives
97.  Various  parameters  such  as  temperature,  ionisation 
additives, and gas flow rates have been detailed. 
 
Cole et al. have developed a fast SFC method for the group separation of glycerol, 
FFA, FAME, the main target compounds for bio-diesel analysis. Using a C18 
column the groups were separated within the analysis time of 35 mins which is a 
threefold and a fivefold increase in throughput compared to UPLC and HPLC 
respectively. Glycerol eluted first and FAME last.
98 
 
1.5.5   Synthetic oligomers, polymers, and polymer additives 
 
Pure CO2 was used as the mobile phase for the separations of ethoxylated and 
propoxylated oligomers and detected with both flame ionisation detectors and low 
wavelength UV absorbance detectors, both options were found to give equivalent 
results.
99  Separations  of  ethoxylated  alkylphenols  with  coupled  diol  and  CN 
packed  columns  produced  the  best  results  for  SFC.  Although  SFC  provided 
chromatographic  resolution  similar  to  HPLC,  a  shorter  analysis  time  was 
achieved.
100 In another instance, a 1 m long packed column was used for high 
resolution SFC-MS separations of alkoxylated oligomers.
101 
 
Takahashi et al. have shown that the sensitivity of corona CAD is higher than that 
of  ELSD  for  the  analysis  of  synthetic  polymer  by  SFC
102.  The  analysis  was 
performed  using  a  silica  gel  column  and  CO2  with  MeOH-H2O  (9:1  v/v)  as   32 
modifier solvent using gradient conditions. The limit of detection was 10 times 
lower than ELSD. 
 
1.6  Aims and Objectives of the project 
 
SFC coupled to mass spectrometry, with an electrospray ion source, was used to 
analyse  diverse  series  of  test  compounds.  The  simple  coupling  of  the  mass 
spectrometer  to  the  SFC  resulted  in  no  significant  loss  in  chromatographic 
integrity to the UV detected peaks - the MS detector affording identification of 
compounds with no or poor UV chromophores. The MS was particularly useful in 
identifying and confirm unknowns, peaks resulting from unusual chromatographic 
effects  and  also  to  track  the  presence  of  the  organic  acids  or  bases  used  as 
additives. The ionisation of samples in the absence of high voltage, i.e. ionisation 
voltages, was observed when a SFC was coupled to an ESI source. This novel 
ionisation process was further investigated. 
 
Compounds showed increased sensitivity with the source high voltages turned off. 
The  involved  mechanism  of  ionisation  for  this  has  not  been  reported  so  far, 
nevertheless the increased sensitivity in the absence of high voltage can help in 
lowering the limit of detection for certain compounds. In this work an attempt was 
made  to  explain  this  ionisation  phenomenon  and  the  improved  sensitivity 
quantified. 
 
To probe this mode of ionisation specific test compounds e.g. diphenhydramine, 
terfenadine, oxybutynin and reserpine were analysed using standard ESI source 
and APCI source conditions. Structures of these test compounds are shown in 
Figure  1.16.  In  both  cases  data  was  acquired  with  the  high  voltage  on 
(electrospray) or off (Novospray). To probe whether this is a thermospray type 
ionisation process, ammonium acetate was introduced as buffer. Similarly, formic 
acid was added to see if charged residue model was the driving  force  in this 
ionisation mechanism. The effect of organic solvent and composition was also 
explored. 




























Figure 1.16: Structures of test compounds 1.Diphenhydramine, 2. Terfenadine, 3. 
Oxybutyin and 4. reserpine 
 
For all the samples analysed by Novospray the resultant signal was comparable or 
better  than  the  classical  ESI  and  APCI  methods.  The  addition  of  ammonium 
acetate did not assist in ionisation, on the contrary this resulted in reduced signal; 
suggesting that it is not a thermospray type of ionisation process. Similarly the 
addition of acid also resulted in reduced signal thus suggesting the molecule is not 
charged in solution as in charged residue model. The other explanation could be a 
variant of sonic spray. Here the ion intensity strongly depends on the gas flow 
velocity, consistent with the high pressure flow from the SFC.  
 
Regardless  of  the  method  of  ionisation,  the  most  important  point  to  note  is 
enhanced  ionisation  with  the  high  voltage  turned  off  in  SFC-MS  system  was 
observed, thus aiding low level detection. This also suggests that the majority of 
the ion current observed in API is independent of applied HV for ESI and APCI. 
 
Another objective was to explore whether SFC, which promises to be cheaper and 
more  environmentally  friendly  than  conventional  HPLC,  can  be  applied  more 
widely  as  a  complementary  method.  Further  in  an  attempt  to  develop  generic 
analytical  and  preparative  methods,  a  diverse  series  of  test  compounds  were 
analyzed on different stationary phase columns with use of a modifier, primarily   34 
methanol. To improve the chromatography on certain stationary phases additives 
have been used, e.g. simple organic acids, bases or ionic salts. This work shows a 
comparison  of  the  different  additives  used  and  a  comparison  of  different 
stationary  phases.  For  some  compound  types  two  peaks  were  observed  upon 
injection, this appears to be linked to compound type and the injection procedure. 
Data attempting to explain this phenomenon is presented and in particular how the 
choice  of  injection  solvent  affects  possible  compound  interactions  with  the 
stationary phase and peak shape.  
 
One of the objectives of this project has been to determine whether a generic set 
of  rules  can  be  applied  to  choosing  the  best  technique  for  the  separation  and 
analysis of a given sample based on the chemistries of compounds involved. Thus, 
a direct comparison of HPLC and SFC was undertaken with a diverse series of 
test compounds using the same conditions, to highlight the effectiveness of the 
two techniques in terms of speed and more importantly compound coverage. The   
successful analysis of polar species by SFC was highlighted i.e. compounds that 
elute with the solvent front of the generic C18 methods used and ascertain which 
factors  are  important  in  determining  the  optimum  technique  for  a  general 
compound class.  
 
HPLC and SFC data are presented, comparing a generic analysis protocol with 
compound specific analyses.  Preliminary findings showing the overlap between 
the two separation techniques is discussed and specific differences observed with 
the different column types used is outlined.  
   35 
Chapter 2  
SFC  –  MS  Ionisation  in  absence  of  high  voltage:  - 
Novospray   
 
 
The coupling of HPLC to MS used to be a difficult process due to the transition of 
liquid phase ions at atmospheric pressure to gas phase ions in a vacuum. The 
difficulties would involve introducing solutions to the vacuum system of the mass 
spectrometer. One solution is to apply heat to aid evaporation, but this can lead to 
the thermal degradation of the analyte. One other issue is the capacity of vacuum 
pumps to deal with a large gas load i.e. 1 mL of solvent creating approximately 
1 L of vapour. In order to couple a liquid chromatograph to a mass spectrometer, 
the interface must be capable of evaporating liquids into gases. It must then be 
able to ionise the species present and finally remove the large amounts of solvent 
whilst maintaining the required vacuum for the mass analysers. SFC-MS has been 
recognised as a favourable player due to the growing need for high speed and high 
quality separations. When combined with MS the CO2 mobile phase of SFC is 
more easily handled by the vacuum system due to its high volatility. Further it can 
enhance volatilisation of the sample and residual solvent (modifier) at the inlet to 
the  mass  analyser.  The  coupling  of  SFC  to  MS  has  resulted  in  a  powerful 
analytical tool for the analysis of complex mixtures.  
 
In this project, an interesting observation of analytes ionising in the absence of 
high source voltage was noted when the SFC was interfaced to the MS via an 
electrospray  interface.  The  SFC  system  was  directly  coupled  to  the  mass 
spectrometer. A post column make-up flow of methanol was introduced prior to 
the MS interface for the following reasons. Firstly, after the restriction, the fluid 
density,  and  the  solvating  power  of  pure  CO2  is  reduced.  This  may  result  in 
precipitation of the analytes before reaching the MS. Secondly the presence of a 
polar modifier is required to maintain ionisation of samples, as CO2 is not known 























































Figure 2.1: Structures of standard compounds used. 
 
In this study, compounds were analysed on the SFC-MS set-up. Commonly a 
methanol make-up flow is introduced using an HPLC pump. For the purpose of 
ionisation  studies  the  methanol  make-up  flow  was  replaced  with  acidified 
methanol to observe the effect of additional H
+ ions. Similarly the make-up flow 
was then replaced with ammoniated methanol to observe the effect of excessive 
NH4
+ ions. Another condition was to avoid using any make-up flow from the 
HPLC. The results obtained showed that the post column make-up flow may not 
be necessary if sufficient amount of polar modifier is used in SFC, for e.g. where 
modifier  percentage  is  20%  or  more.  To  help  probe  the  phenomenon  of  this 
ionisation process i.e. ionisation in the absence of high voltage, test compounds   
like  diphenhydramine,  terfenadine,  oxybutynin  and  reserpine  were  chosen. 
Structures  of  the  test  compounds  are  shown  in  Figure  2.1.  Their  structural   37 
differences covered the different ionisation properties of a pharmaceutical library. 
Thus allowing for the application of Novospray to be probed and understood.  
  
The initial findings, with relation to ionisation in the absence of any high voltages 
applied to the ion source lead to the following discussion related to the actual 
source  of  ionisation.  There  are  several  solution  based  ionisation  processes  in 
literature, API techniques of ESI and APCI, other reported and used processes are 
TSP, PSP or sonic spray etc. 
 
Table 2.1: Experimental conditions of make-up solvent, ion source high voltage and 
cone voltage 
High voltage (kV)  Desolvation temp 
(°C)  Make-up solvent 
ESI  APCI 
Cone 
Voltage (V) 
ESI  APCI 
Pure MeOH 
MeOH  + 0.1% NH4OAc 
MeOH  + 0.1% HCOOH 
No make-up 
3.5  3.2  20  200  400 
Pure MeOH 
MeOH  + 0.1% NH4OAc 
MeOH  + 0.1% HCOOH 
No make-up 
0  0  20  200  400 
 
 
In order to ascertain if ionisation mechanism followed the electrospray charged 
residue  model  type,  acid  was  added  to  the  post  column  make-up  solvent  to 
facilitate the protonation of molecules, i.e. increase the population of [M + H]
+ 
ions in the system. Another option considered was that of thermospray type of 
ionisation process. Thermospray ionisation is enhanced through the presence of a 
volatile  buffer  such  as  ammonium  acetate.  This  initially  affords  ammoniated 
molecules, [M + NH4]
+, these can subsequently undergo collision within the ion 
source (often prompted by use of a repeller electrode) to produce the protonated 
molecule, [M + H]
+. Addition of ammonium acetate to the post column make-up 
solvent prior to mixing of the SFC eluent was investigated to see whether the 
novospray  ionisation  process  was  thermospray  like.  To  probe  whether 
thermospray like processes were involved, 0.1% NH4OAc in methanol was used 
as make-up solvent. The presence of the volatile buffer would be expected to aid 
the  ionisation  process  if  it  was  related  to  thermospray.  All  experiments  were   38 
repeated  using  an  APCI  source  configuration  to  investigate  if  the  novospray 
ionisation  process  was  dependent  on  the  configuration  of  the  source.  To 
investigate  whether  novospray  is  related  to  or  is  a  variant  of  sonic  spray  the 
variation of pressure, modifier percentage and the flow rate were studied. 
2.1  High Voltage 
 
During the coupling of SFC and MS, ionisation of samples in the absence of high 
voltage  was  observed.  To  investigate  the  ionisation  mechanism  involved, 
compounds  1 to  4  shown  in  Figure  2.1  were  analysed,  in  triplicate,  using  the 





































































































Figure 2.2: Plot of ionisation respose versus choice of make-up solvent using an ESI 
and an APCI source for (a) diphenhydramine and (b) oxybutynin. Number of 
replicates = 3 
 
The results using the ESI source configuration are explained below. Figure 2.2  
and  Figure  2.3  show  when  pure  methanol  was  used  for  make-up  solvent  for 
diphenhydramine, oxybutynin and reserpine, the novospray ionisation response is   39 
greater  than  the  ionisation  response  for  the  same  sample  under  normal 
electrospray  conditions.  For  e.g.  Figure  2.4  shows  the  spectra  of  reserpine 
recorded  under  ESI  and  novospray  conditions.  In  both  cases  the  protonated 
molecule for reserpine can be observed. Although in the case of terfenadine the 
novospray response is less than normal electrospray response, ionisation is still 
observed  at  0kV.  This  suggests  that  there  is  an  underlying  ionisation  process 
involved  that  is  not  directly  related  to  electrospray  ionisation  as  described  by 
either IEM or CRM. To investigate if the ionisation processes can be explained by 
the charge residue model (CRM) of ESI, the make-up solvent was then changed to 
0.1% HCOOH in methanol. In CRM the ions are preformed in solution and the 


































































































Figure 2.3: Plot of ionisation response versus choice of make-up solvent using an ESI 
and an APCI source for (a) terfenadine and (b) reserpine. Number of replicates = 3 
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Figure 2.4: Mass Spectra of reserpine recorded at 3.5 kV and 0 kV showing the 
protonated molecule m/z = 609.  
 
 
Diphenhydramine was also analysed under similar conditions. The sensitivity of 
diphenhydramine was noticeably increased using novospray conditions with pure 
methanol as make-up solvent. Diphenhydramine easily fragments to give m/z 167 
under  both  normal  ESI  and  novospray  conditions.  The  peak  areas  for  the 
reconstructed ion chromatogram (RIC) of m/z 256 and m/z 167 were plotted as 
shown in Figure 2.5. When pure methanol was used as the make-up solvent the 
ratio of m/z 256 to m/z 167 remained constant irrespective of whether the ESI high 
voltage was on or off, i.e. no more or no less fragmentation was observed for 
electrospray  or  novospray.  Addition  of  NH4OAc  favoured  fragmentation  of 
diphenhydramine whereas the addition of acid did not. 
 
All experiments were repeated using an APCI source configuration to investigate 
if the novospray ionisation process was dependent upon the configuration of the 
source.  As  shown  in  Figure  2.2  the  results  using  APCI  were  found  to  be 
comparable to the results observed using the ESI source configuration. In both 
ESI  and  APCI  the  sensitivity  dropped  when  NH4OAc  as  introduced  to  the 
methanol  make-up  solvent  and  slight  variation  in  sensitivity  was  observed  on 
addition of 0.1% HCOOH to methanol make-up solvent. The sources differ in the 
[M + H]+ 
HV = 3.5kV 
[M + H]+ 
HV = 0kV   41 
capillary types. The ESI source has a stainless steel capillary of 127 micron i.d. 
and the APCI source has a 100 micron i.d. fused silica capillary. The above results 
indicated  that  the  ESI  and  APCI  interface  both  exhibited  ionisation  under 
novospray conditions and that ionisation is independent of the capillary type. In 
each case the signal observed was comparable or better than normal ESI, thus 
suggesting that the observed mechanism of ionisation for novospray is not related 
to the high voltage applied to the droplet. Further, novospray is an underlying and 
major process within the electrospray ionisation process. Similarly, this process is 
underlying  in  APCI  and  may  explain  the  regular  observation  of  cationised 
molecules,  e.g.  [M  +  Na]
+  which  cannot  be  formed  as  part  of  a  gas  phase 
ionisation process. 
 
































HV = 0 kV
 
 
Figure 2.5: Ionisation response for Diphenhydramine with different make-up 
solvents for ratio of protonated molecule m/z = 256 to fragment ion m/z = 167. 
Number of replicates = 3 
 
To understand the influence of applied voltage to the ionisation process, a study 
was  carried  out  using  four  compounds  (3-6  shown  in  Figure  2.1)  at  different 
voltage steps between 0 and 5 kV. To avoid any residual charge the compounds 
were analysed starting from 0 kV and increased up to 5 kV, in increments of 
0.5 kV. As seen from the results for oxybutynin in Figure 2.6 about 70% of the   42 
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Figure 2.6: Dependence of ionisation response of ESI source high voltage for 
oxybutynin. Number of replicates = 3 
 
 
2.2  Modifiers and Pressure conditions of SFC 
 
In SFC the inability of non-polar CO2 to elute very polar or ionic compounds is 
overcome  by  the  addition  of  a  small  amount  of  a  polar  organic  solvent.  This 
organic solvent is referred to as the modifier when it is added directly to the 
mobile phase. The addition of a modifier improves the solvating properties of the 
supercritical fluid and sometimes enhances the selectivity of separation. It can 
also help improve separation efficiency by blocking some of the highly active 
sites on the stationary phase. Methanol is the most commonly used modifier in 
SFC  as  it  produces  high  efficiency  separation.  Whilst  other  modifiers  were 
investigated such as ethanol, propanol, all analyses reported here were undertaken 
using methanol modifier. The effect of changing the modifier on the novospray 
ionisation was considered. Therefore a less polar solvent, acetonitrile was chosen.  
   43 
Comparison of Acetonitrile and Methanol modifiers






















Figure 2.7: Comparison of ionisation response for MeOH and MeCN modifiers at 
ESI source HV = 0 kV and HV = 3.5 kV. Number of replicates = 3 
 
A  comparative  FIA  analysis  was  undertaken  using  acetonitrile  in  place  of 
methanol.  The  results  in  Figure  2.7  show  a  drop  in  sensitivity  when  using 
acetonitrile as modifier particularly for nicotinanilide and mebendazole. This loss 
of sensitivity compared with the methanol experiments might be due to the acidic 
nature  of  methanol.  The  slightly  acidic  proton  of  the  hydroxyl  group  may  be 
assisting  in  protonation  of  the  molecule,  resulting  in  improved  ionisation  in 
comparison to the analyses in acetonitrile. Although the sensitivity drops, the plot 
for  oxybutynin  shows  that  the  ratio  of  novospray  ionisation  to  electrospray 
ionisation using acetonitrile is comparable to that with methanol modifier. This 
behaviour is also observed for the other compounds. The sensitivity is greater 
under  novospray  conditions  with  methanol  make-up  flow  for  compounds  4-6. 
This appears to show that the mobile phase composition of CO2 and methanol is 
an important factor of the novospray ionisation. To confirm this, a mixture of 
three compounds (2, 3 and 7 shown in Figure 2.1) was analysed using FIA-ESI-
MS  with  voltage  conditions  similar  to  novospray.  The  analytes  ionised  in  the 
absence of high voltage on the FIA-ESI-MS system but with very low sensitivity. 
The enhanced ionisation in the SFC-MS system was thought to be related to the 
pressure, CO2 flow rate and properties of the expanding supercritical/subcritical 
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Figure 2.8: Dependence of ionisation response for flow injection analysis for the 
protonated molecule on pressure and modifier for a mixture of terfenadine, 
oxybutynin and erythromycin at pressure  (a) 75 bar, (b) 100 bar, (c) 150 bar, and at 
10, 20 and 50% modifier concetration.  
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Figure 2.9: Dependence of ionisation response on percentage modifier for a mixture 
of terfenadine, oxybutynin and erythromycin at 100 bar pressure.  
 
Another possibility considered to be the route to ionisation was sonic spray. Here 
the  ion  intensity  strongly  depends  on  the  gas  flow  velocity.
61  Sonic  spray 
ionisation was first developed by Hirabayashi and co-workers. In this technique   45 
the eluent is sprayed from a fused silica capillary with gas flow coaxial to the 
capillary  resulting  in  the  formation  of  ions  and  charged  droplets  under 
atmospheric pressure. In sonic spray ionisation it is not necessary to apply heat or 
an  electric  field  to  the  capillary  of  the  ion  source.  To  investigate  whether 
novospray is related to or is a variant of sonic spray the variation of pressure, 
modifier  percentage  and  the  flow  rate  were  studied.  Initial  experiments  were 
performed using the same test mixture (compounds 2, 3 and 8 shown in Figure 
2.1) at 75, 100, and 150 bar and the mobile phase modifier percentage at 10, 20, 
and 50 organic using the SFC-MS system.  
 
The plots showing the ionisation response for each of the conditions are in Figure 
2.8. Reduced responses were observed at 75 bar in comparison to peak areas at 
100 bar.  Further at 75  bar pressure using 20% and 50% methanol modifier a 
noticeable increase in the novospray ionisation was observed in comparison to 
ESI.  With  the  same  modifier  percentages  at  150  bar  pressure,  a  decrease  in 
sensitivity for both ESI and novospray was observed. Also at 150 bar pressure ESI 
was the dominant process. In all cases novospray ionisation was observed. Since 
maximum  sensitivity  was  achieved  at  100  bar  the  effect  of  modifier  was  the 
studied over a percentage range in the mobile phase from 5 to 50 % (Figure 2.9). 
The optimum modifier condition for maximal ionisation was found to be 30 % at 
100 bar pressure.  
 
The  initial  work  undertaken  at  three  different  pressure  conditions  was  further 
extended  over  a  range  of  pressure  starting  from  50  bar  up  to  150  bar  with 
increments  of  10  bar  as  shown  in  Figure  2.10.  Once  again  four  structurally 
different compounds (2, 4, 5 and 6 shown in Figure 2.1) were analysed. All the 
standards  showed  similar  trends  with  increases  in  pressure.  Under  novospray 
conditions the best sensitivity was obtained at around 90 -100 bar.  
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Oxybutynin
Pressure (Bar)



















































































Figure 2.10: Dependence of ionisation response on pressure for (a) oxybutynin, (b) 
nicotinanilide, (c) mebendazole and (d) reserpine. Number of replicates = 3 
 
2.3  SFC flow rate  
 
The  eluent  flow  rate  is  also  one  of  the  important  parameters  in  SFC.  Since 
novospray ionisation could be considered as a variation of sonic spray, varying 
the flow rate would affect the ionisation. The standards were analysed at different 
flow rates from the lowest possible 1.5 mL min
-1 to 5.5 mL min
-1 with increments 
of 0.5 mL min
-1. The plots of peak areas against the flow rate are shown in Figure 
2.11.  A  similarity  in  trend  under  novospray  conditions  was  observed  for  all 
standard  compounds.  Sensitivity  of  the  analytes  remains  steady  from  1.5  to 
3.5 mL min
-1 but decreases above a flow rate 4 mL min
-1. There could be two 
possible explanations for this observation. Firstly, as the flow rate is increased the 
amount of solvent is increased and this could result in an ineffective desolvation 
process. Secondly, as the flow rate is increased the size of the droplet leaving the 
tip of the API capillary could be larger; moving faster and so may take longer to 
evaporate before it attains the required size and desolvation state prior to entering 
the skimmer cone. This could be overcome by increasing the distance between the   47 
end  of  the  API  capillary  and  the  skimmer  cone.  This  is  demonstrated  using 
mebendazole as shown in Figure 2.12. Here, increased sensitivity was observed 
on increasing the distance, thus indicating that the droplet size at higher flow rates 
has an impact on sensitivity. This may be due to the size of the droplet formed at 
higher  flow  rates  being  bigger  at  the  default  distance  between  the  tip  of  the 
capillary. It was not possible with the instrument configuration used to adjust the 
distance sufficiently to optimise the desolvation process. These data suggesting 
that novospray has similarities to sonic spray. 
Oxybutynin
Flow mL min-1















































































Figure 2.11: Dependence of the ionisation response on the SFC flow rate. (a) 
oxybutynin, (b) reserpine, (c) nicotinanilide and (d) mebendazole. Number of 
replicates = 3 
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Mebendazole
Distance of API capillary and skimmer cone 



















Figure 2.12: Plot showing increased ionisation on increasing the distance between 









STD2-h5 28 (0.597) 1: Scan ES+ 
4.59e5 358







478 396 402 456
442












STD2-c1 28 (0.588) 1: Scan ES+ 
3.19e5 358
94











Figure 2.13: (a)Base peak ion chromatograms of flow injection analysis of 
oxybutynin showing increased sensitivity in the absence of high voltage; (b) mass 









(c)   49 
From  the  above  results  a  definitive  ionisation  mechanism  could  not  be 
determined. A variant of sonic spray ionisation with charge residue model-type 
formation of analyte ions is a plausible mechanism, given the experimental data. 
Although the ionisation mechanism is not confirmed, the important point to note 
is that increased response can be achieved, in the absence of source HV, when 
using SFC-MS system with methanol modified CO2 mobile phase. This ultimately 
could assist in lowering the limit of detection for such compounds as shown in 
Figure 2.13. 
 
2.4  HPLC-ESI-MS and SFC-ESI-MS comparison 
 
 
The novospray type of ionisation was first noticed when the SFC was coupled 
with MS and assumed to be specific to that specific instrument configuration. 
Hence to confirm that ionisation of compounds in the absence of high voltage is 
unique  to  SFC,  a  test  mix  which  was  a  mixture  of  terfenadine,  oxybutynin, 
erythromycin was introduced into the same mass spectrometer using an HPLC 
pump at a flow rate of 0.1 mL min
-1.  
 
Interestingly a similar phenomenon, i.e. ionisation in the absence of ion source 
high voltages, was observed but the response was less than half when the HV was 
off  compared  to  that  observed  for  standard  electrospray  conditions.  The 
experiment was then repeated at a flow rate of 1 mL min
-1 and this time the peak 
areas were similar to that of 0.1 mL min
-1 for both electrospray and novospray 
conditions. In comparison approximately 20% more sensitivity was observed with 
SFC-MS  than  HPLC-MS  under  novospray  conditions.  The  SFC  was  operated 
using 20% methanol modifier at 100 bar pressure and with a flow of 3 mL min
-1. 
The sensitivity did not vary when the voltages were on or off in case of SFC.  The 
chromatograms and spectra are shown in Figure 2.14 and Figure 2.15. For both 
SFC and HPLC a flow injection analysis was undertaken and the spectra for each 
were noted.  In the spectrum, in case of HPLC terfenadine was the base peak 
whereas in case of SFC it was oxybutynin. 
   50 
 
 




















7 7 4 24 5 6 4 125 32 26 4
 









37 218 699 171 16 117 42





















0 1 6 1











Figure 2.14: Base peak ion chromatograms of test mix (a) HPLC flow at 0.1 mL min
-
1 with HV on and off (b) HPLC flow at 1 mL min
-1 with HV on and off (c) SFC-MS 




(a) HPLC: 0.1mL/min 







(c) SFC-MS   51 
 
Figure 2.15: Spectra of test mix (Chromatograms shown in Figure 2.14) (a) HPLC 
flow at 0.1 mL min
-1 with HV on and off (b) HPLC flow at 1 mL min
-1 with HV on 
and off (c) SFC-MS with HV on and off. Sensitivity comparison of HPLC-ESI-MS 
and SFC-ESI-MS. 
2.5  Experimental Section  
 
 Chemicals and reagents  
 
HPLC grade methanol was purchased from Fisher Scientific (Loughborough, UK) 
and SFC grade CO2 from BOC gases (Guildford, UK). Formic acid (HCOOH) 
(Riedel-de Haën Seelze, Germany) and ammonium acetate (NH4OAc) (Sigma-
Aldrich,  Gillingham,  UK)  were  used  for  the  make-up  solvent.  Standard 
compounds  diphenhydramine,  oxybutynin  chloride,  terfenadine,  reserpine  and 
mebendazole  (Sigma-Aldrich,  Gillingham,  UK),  erythromycin  (Fluka, 
Switzerland)  and  nicotinanilide  (Lancaster,  Morecambe,  England)  were  used 
without further purification. Structures of the standards are given in Figure 2.1.  
No SFC, HV:3.5kV,CV: 20V, HPLC:0.1mL/min
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Instrumentation 
 
A  Minigram  SFC  system  (Berger  Instruments,  Mettler-Toledo  Autochem, 
Newark, DE, USA), equipped with a FCM-1100/1200 dual-pump fluid control 
module, a TCM-2250 heater control module, an ALS 3100/3150 autosampler and 
a Knauer k-2501 variable wavelength UV detector (Knauer,  Berlin, Germany) 
were used in all experiments. The system was controlled and data acquisition was 
undertaken  using  PRONTO  software  (v1.5.305.15,  Berger  instruments).  The 
eluent  was  split  before  the  backpressure  regulator  using  a  zero  dead  volume 
stainless steel T-piece. 1524 mm length of 0.10 mm i.d. PEEK tubing was used to 
interface the SFC eluent to a Micromass Platform LCZ mass spectrometer, the 
latter fitted with a standard ESI Z-spray ion source. The mass spectrometer was 
controlled by MassLynx software (v3.5). Another zero dead volume stainless steel 
T-piece was used to connect a HP1050 HPLC system (HP, Agilent, Palo Alto, 
California)  to  deliver  a  make-up  flow  of  solvent  at  0.1 mL min
-1  to  the  API 
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Experimental conditions 
 
Individual  stock  solutions  of  each  compound  were  prepared  in  methanol  at  a 
concentration of 1 mg mL-1. New solutions were freshly prepared everyday with 
each component at a concentration of 0.1 mg mL-1 in the mixture. The analytes 
were  analysed  isocratically  at  modifier  concentrations  in  the  mobile  phase 
between 5-50 % organic solvent. The pressure was set at 100 bar, oven 35 °C, 
flow rate 3 mL min-1  and a 2 µL injection volume used. All standards were 
analyzed using a 2-EP column, 50 mm x 4.6 mm, 5 µM, 60 Å pore size (Princeton 
Chromatography, Cranbury, NJ, USA). The UV detector was set at a wavelength 
of 220 nm.  Both positive ion and negative ion mass spectra were recorded. The 
MS conditions are shown in  
Table 2.2. The make-up flow consisted of (i) pure methanol, (ii) 0.1 % NH4OAc 
in methanol and (iii) 0.1 % formic acid in methanol. The make-up flow rate was 
delivered at 0.1 mL min
-1. 
 
Table 2.2: Typically LCZ parameters used for ESI and APCI analyses. 

































2.6  Conclusions 
 
Compounds 1-7 (See Figure 2.1) were analysed using SFC-ESI-MS under normal 
electrospray  conditions  and  with  no  high  voltage.  Ionisation  was  observed 
unexpectedly in the absence of high voltage. Analytes ionised in the absence of 
high voltage indicating the mechanism of ionisation in the SFC-MS system with 
supercritical CO2 mobile phase does not exhibit typical electrospray ionisation. 
Three  possible  existing  mechanisms  were  considered  as  contributing  to  this   54 
ionisation.  These  were  thermospray  ionisation,  charge  residue  model  for 
electrospray ionisation and sonic spray ionisation.  
 
The presence of NH4OAc suppressed ionisation, suggesting that the thermospray 
type mechanism was unlikely. The addition of acid to the eluent to determine if 
the CRM type process existed showed very little variation in sensitivity; whereas 
a stepwise source high voltage study, over a range of 0 and 5 kV, indicated little 
variation in sensitivity suggesting the possibility of preformed ions in solution. 
This suggests that it may not be a complete CRM type process.  
 
Novospray ionisation was found to be dependent on the pressure, modifier, and 
the  flow  rate  of  the  SFC  system  but  independent  of  the  ESI  ion  source 
configuration since novospray ionisation was also observed when an APCI source 
configuration was used. The results obtained with the latter were comparable in 
both  cases  indicating  either  source  is  suitable  to  be  interfaced  with  the  SFC 
system.  
 
A comparative study using acetonitrile and methanol as modifier suggests that the 
acidic  nature  of  methanol  may  play  a  role  in  assisting  in  protonation  of  the 
molecule. This could again suggest a CRM-type of process. The mechanism of 
ionisation in the SFC-MS system when the API voltages are turned off was found 
to be similar to that of sonic spray ionisation consistent with the charge residue 
model. Another consideration might be that the ion formation is possibly due to 
collision of molecules in the free jet expansion region of the of the SFC eluent.   55 
 
Chapter 3  
SFC Method Development and comparison with HPLC 
 
3.1  Introduction 
 
The need for efficient high speed separations has resulted in further development 
of chromatographic systems. Amongst these chromatographic systems, some use 
higher  pressures  whilst  others  use  improved  stationary  phase  materials  for 
columns.  
 
Packed column SFC is another such development in which changing the mobile 
phase has resulted in efficient chromatographic separations. Packed column SFC 
has recently experienced tremendous growth as an analytical technique. It is a 
technique similar to HPLC that uses a supercritical fluid for the mobile phase. 
Retention of the analyte in SFC is a function of temperature, pressure, mobile 
phase density, mobile phase composition and the stationary phase. Furthermore, 
there may be the interaction with the packing material, i.e. silica, making it more 
complex  than  other  chromatographic  techniques.  Many  of  these  variables  are 
inter-related and do not change in a predictable manner.  
 
The aim of this project was to develop a near generic SFC method for compounds 
of  pharmaceutical  importance.  The  instrumental  conditions  of  the  SFC  were 
varied to be able to achieve optimised conditions for the analyses of the given 
type of compounds. SFC is classed as a normal phase technique as pure CO2 is 
non polar to solvate polar molecules binary mixtures ere used as the mobile phase 
to increase the polarity range. The solvent added to increase polarity is called the 
modifier. Although methanol is the most commonly used modifier in SFC the 
effects of other modifiers were studied by replacing methanol with ethanol, 2-
propanol, and comparing the results.   56 
 
A comparative study of the available stationary phases was undertaken to decide 
on the best suited column for the compound types investigated. These were 2-
ethylpyridine (2-EP), cyanopropyl (CN), polypropyl urea (PPU), and diol. In all 
cases 20% methanol modified CO2 was used.  
 
Additives  are  used  in  the  mobile  phase  in  small  quantities  to  improve  the 
chromatography  of  the  analytes.  In  this  case  the  additives  were  added  to  the 
mobile phase when analysing compounds using a CN column. Most compounds 
had sharp and narrow peaks on other columns i.e. 2-EP, hence the addition of 
additives  did  not  show  any  noticeable  improvement  in  chromatography.  The 
retention time also did not change much either. 
 
These  results were assessed with regard to, e.g. speed of  analysis, number of 
theoretical plates, resolution etc. The compounds analysed for the above study 
consisted of a series of discreet libraries, a training set of compounds, a diverse set 
that  covered  the  chemical  space  of  typical  pharmaceutical  compounds  and  a 
focused set. The latter consisted of compounds with similarity in structures, but 
with subtle differences at two positions on the basic structure, as seen in Figure 
3.1. The structures of all the compounds analysed are shown in the Appendix 1-4.  
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R  1  = H, CH(CH  3  )2  , CH  2  C  6  H5  , 
CH  2  OH, CH  2  COOH 
R  2  = (CH  2  )2  NH  2  , (CH  2  )3  NH  2  ,   57 
The combined results from the studies of stationary phase, modifiers, additives 
resulted developing methods wherein most of the compounds being analysed with 
little or no difficulty. The efficiency N, asymmetry and HETP were calculated and 
compared  for  different  modifiers,  stationary  phase  and  additives  to  enable 
determination of the most suitable parameter.  However, a number of samples 
proved problematic, showing non ideal responses e.g. insolubility of analytes in 
methanol, peak splitting. An attempt to explain the reasons for the observations 
has been made. The possible solutions to tackle such variations are shown in this 
section.  
 
A  comparative  study  of  SFC  and  HPLC  was  undertaken  to  understand  the 
compound coverage of each technique; the speed of analysis was also considered. 
To be able to decide on the most suitable technique of analysis between HPLC 
and SFC, based on the chemical structures of the analytes, a comparative study 
was also undertaken. The overall results of a generic SFC method were compared 
with a generic HPLC method and the results are discussed towards the end of this 
chapter. A trend in retention times based on the structures and substructures of 
compounds was noted for a class of compounds. This trend was observed for the 
focused  set.  The  substructure  of  the  side  chains  was  classified  as  aliphatic, 
aromatic. This trend could not be further explored as a result of the unavailability 
of compounds with similarity in structures.  
3.2  Method development 
 
The given sets of compounds were analysed using modified CO2 for mobile phase 
with  the  following  conditions.  The  outlet  pressure  was  set  at  100  bar,  oven 
temperature  35
oC,  flow  rate  4  mL  min
-1  with  a  4  µL  injection  volume.  The 
pressure was altered between 80 bar and 150 bar and the temperature up to the 
instrument limit of 40ºC. These changes were made one at a time maintaining the 
other parameters at initial conditions. Changing the pressure or temperature did 
not affect the peak shapes but only slightly changed the retention times. Factors 
like  modifiers,  additives  and  stationary  phases  were  explored  to  achieve  an 
optimised method for compounds of pharmaceutical interests by SFC. 
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3.2.1  Modifiers 
 
Pure  CO2  is  known  to  be  unsuitable  for  analysis  of  most  pharmaceutical 
compounds on packed column SFC, due to its poor solvating ability. Hence the 
addition  of  small  amounts  of  polar  modifiers  is  necessary.  Depending  on  the 
temperature and pressure of the chromatographic systems, mobile phase modifiers 
are  known  to  affect  the  retention,  selectivity  and  efficiency.
103  During  the 
preliminary  study  of  SFC,  a  training  set  of  compounds  (Structures  shown  in 
Appendix 2 on Pages112-114) was provided to familiarise the operator with the 
use of the SFC instrument. This set was used to choose the most suitable modifier. 
Methanol, ethanol, and propanol were used as the mobile phase modifiers under 
default instrument conditions and the results compared. Figure 3.2 shows the plot 






















































Figure 3.2: A comparison of retention times for the training set using modifiers 
methanol, 2-propanol and ethanol. In each case 20% modifier under isocratic 
conditions was used. 
 
With 20% methanol (isocratic) most compounds eluted with sharp and narrow 
peak shapes with minimal tailing on 2-EP in comparison to PPU and CN columns. 
20-25%  compounds  did  not  elute  under  these  conditions  with  2-propanol  and 
ethanol.  Most  of  these  compounds  were  with  acid  and/or  sulphonamide 
substructures.  Compounds  with  amide  substructures  give  broad  peaks  with 
ethanol. Examples of the chromatography for selected compounds are shown in 
Figure 3.3 and Figure 3.4. 
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Figure 3.3: An example showing peak shapes for analyte GSK1, GSK6 and GSK12 
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Figure 3.4: An example showing peak shapes for analyte GSK15 and GSK16 with 
modifiers, methanol, ethanol, and 2-propanol. 
 
From the raw data the values for the retention factor k′, number of theoretical 
plates N, and height equivalent of theoretical plates HETP was calculated. These 
parameters for the training set are listed in Table 3.1 for selected compounds. 
Overall  the  modifiers  show  varied  effectiveness.  However,  when  methanol 
modifier is used most compounds show large N values. The scatter plot in Figure 
3.5 confirms this finding.  
 
Most small N value compounds also show larger HETP values. Figure 3.6 shows 
scatter  plot  of  HETP  values.  But  closer  observation  shows  that  the  methanol 
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Table 3.1: Values of k', N and HETP for selected compounds from Figure 3.2. 
  methanol  2-propanol  ethanol 
  k'  N  HETP  k'  N  HETP  k'  N  HETP 
GSK 1  1.10  5689  0.0439  8.60  41  1.2004  5.65  81  0.6150 
GSK 5  3.40  1529  0.0327  4.80  1495  0.0334  4.55  1369  0.0365 
GSK 6  5.40  28  1.7578  9.95  42  1.1875  6.15  87  0.5686 
GSK 7  0.90  641  0.0779  1.10  441  0.1134  1.10  441  0.1134 
GSK 8  3.45  1267  0.0395  4.90  1136  0.0440  4.80  1098  0.0455 
GSK 9  10.90  1156  0.0433  18.90  532  0.0939  18.25  421  0.1186 
GSK 11  18.35  95  0.5209  --  --  --  19.55  20  2.3843 
GSK 13  2.05  1215  0.0412  2.75  900  0.0556  --  --  -- 
GSK 14  20.30  1909  0.0262  --  --  --  30.45  918  0.0544 
GSK 15  10.55  1764  0.0283  19.10  2236  0.0224  17.55  1699  0.0294 
GSK 16  18.65  2137  0.0234  22.05  1539  0.0325  21.50  1296  0.0386 
GSK 19  8.05  1188  0.0421  11.05  241  0.2068  19.10  32  1.5597 
 
 
The statistics of mean and standard deviation from these data tables can assist in 
determining the suitable modifier. For N values this statistics is given in  
Table  3.2.  Large  mean  value  and  small  standard  deviation  of  N  is  the  ideal 
combination for a suitable modifier. The varied performance of modifiers comes 
clearly further from this Table. The highest mean, however, is seen for methanol 
modifier. Similarly for HETP values, the statistics is listed in Table 3.3. Here the 
ideal  combination  is  of  low  mean  and  standard  deviation.  Methanol  and  2-
propanol show similar statistics with methanol showing marginally smaller mean 
value.  
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N value
Compound number













Figure 3.5: Scatter plot showing the spread of N values data for the modifiers 
methanol, 2-propanol and ethanol. 
 
 
Table 3.2: Statistical data of N values of the peaks for modifiers methanol, 2- 
propanol and ethanol. 
N  methanol  2-propanol  ethanol 
Mean  1576  860  708 




















Figure 3.6: Scatter plot showing the spread of HETP data for the modifiers 
methanol, 2-propanol and ethanol. 
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Table 3.3: Statistical data of HETP values of the peaks for modifiers methanol, 2- 
propanol and ethanol. 
HETP  methanol  2-propanol  ethanol 
Mean  0.2271  0.2990  0.5022 
Std Dev  0.4684  0.4749  0.8035 
 
Another parameter that might help determination of better modifier is the scatter 
plot of peak asymmetry for the same compounds. This is shown in Figure 3.7. 
From the peak asymmetry data methanol modifier performs far better overall. The 
statistics  for  peak  asymmetry  are  listed  in  Table  3.4.  The  ideal  situation  is 
combination of mean tending to unity and smaller standard deviation. Here as 
seen  in  scatter  plot  earlier,  methanol  performs  much  better  than  other  two 
modifiers. As methanol performs better for large number compounds than others, 
it appears suitable as a universal modifier. 
Compound Number






















Figure 3.7: Scatter plot showing the spread of asymmetry data for the modifiers 
methanol, 2-propanol and ethanol. 
 
Table 3.4: Statistical data of asymmetry of the peaks for modifiers methanol, 2- 
propanol and ethanol. 
Asymmetry  methanol  2-propanol  ethanol 
Mean  1.4413  2.2536  2.3506 
Std Dev  0.7807  1.3429  1.5184 
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From the above results it can be concluded that methanol is the preferred choice 
of modifier for the elution of polar pharmaceutical compounds under the default 
temperature and pressure conditions in SFC. Methanol also has the favourable 
properties of low viscosity, high polarity with low boiling point and low surface 
tension hence helping in improving the ionisation efficiency and sensitivity for 
MS  in  comparison  to  ethanol  and  isopropanol.  Overall  the  results  indicate 
methanol as the suitable modifier for most compounds in this set. Hence methanol 
was chosen as the modifier. One other reason for the use of methanol is related to 
cost.  Ethanol  is  about  10  times  more  expensive  than  methanol  and  hence  not 
practical with the industries constantly trying to minimise costs. 
3.2.2  Stationary Phases 
 
The packing materials in SFC are very similar to that used in LC columns. Several 
studies have been reported for the selection of stationary phase based on the type 
of solute.
104-107 Here in this project the study was performed on using the five 
types of pSFC columns available. Initial experiments were undertaken were using 
columns 250 mm in length, 4.6 mm I.D., 6 µm particle sizes, and 60 Å pore size. 
The study was then extended to 50 mm in length, 4.6 mm I.D., 5 µm particle 
sizes, and 60 Å pore size. A mixture of analytes were analysed using a 250 mm 
column and a 50 mm column. The separation in peaks was not affected when the 
column length was changed but the retention of the analytes was reduced thus 
resulting in shorter run times. These results suggested that the chromatography 
often  occurred  early  on  in  the  column.  Shorter  retention  of  analytes  not  only 
speeds the entire process but also results in less use of solvents. Hence, smaller 
columns were used for the analyses. All the compounds were analysed using 50 
mm columns with 2-EP, PPU, CN stationary phases. Initial experiments with diol 
and amino stationary phase resulted in the compounds not eluting, hence these 
were not used. The results obtained for the focused library (Structures shown in 
Appendix 1 on pages 110-112) are illustrated in Figure 3.8. This shows that for 
most  compounds  2-EP  gives  the  shortest  retention  times.  All  analyses  were 
undertaken using 20% methanol modified, CO2 mobile phase at a flow rate of 3 
mL min
-1.   65 
Compound numbers






























Figure 3.8: A comparison of retention times for the focused library (EL) for 2-EP, 
PPU, CN.  Column length: 50mm 
 
In Figure 3.8, 71 percent of compounds from the focused set eluted with shorter 
retention times with 2-EP column in comparison to the other two columns i.e. 
PPU and CN column.  
Table 3.5: Values of k', N and HETP for with 2-EP, PPU and CN columns of 
selected compounds from Figure 3.8. 
  2-EP  PPU  CN 
  k'  N  HETP  k'  N  HETP  k'  N  HETP 
EL1  2.50  400.00  0.1250  6.70  60.80  0.8224  23.90  968.77  0.0516 
EL2  2.30  144.00  0.3472  11.55  139.52  0.3584  23.55  2410.81  0.0207 
EL4  2.80  641.78  0.0779  32.45  283.26  0.1765  23.55  971.86  0.0514 
EL5  2.35  498.78  0.1002  15.35  445.07  0.1123  23.30  952.16  0.0525 
EL7  3.30  150.94  0.3313  27.15  291.06  0.1718  24.50  1156.00  0.0433 
EL8  2.90  243.36  0.2055  33.10  309.76  0.1614  24.40  977.28  0.0512 
EL17  4.90  770.88  0.0649  4.55  291.62  0.1715  26.70  19.64  2.5455 
EL18  2.30  144.00  0.3472  3.50  207.36  0.2411  13.35  18.77  2.6643 
EL19  2.25  300.44  0.1664  4.05  564.76  0.0885  13.95  30.66  1.6309 
EL20  2.50  544.44  0.0918  9.25  442.08  0.1131  10.95  30.19  1.6564 
EL21  2.35  498.78  0.1002  3.40  632.16  0.0791  11.10  81.84  0.6109 
EL23  3.30  150.94  0.3313  5.50  400.00  0.1250  12.50  62.15  0.8046 
EL24  2.90  243.36  0.2055  6.60  507.08  0.0986  10.70  40.00  1.2501 
 
   66 
The values of k′, N and HETP for a selected set of compounds are given in Table 
3.5. The N values for 2-EP stationary phase are consistently large in comparison 
to PPU and CN. A large variation is seen for the PPU column. The scatter plot of 
N  clearly  shows  this;  CN  based  data  is  varying  significantly  providing  good 
values for first few compounds and poor results for compounds P17-P24. This 
behaviour is clearly seen in the statistics listed in Table 3.6. The combination of 
lower standard deviation and reasonable mean value shows the good performance 
of 2-EP for the compound set. The HETP data, however, for most compounds 
appears to show similar performance for 2-EP and PPU (Table 3.5). The scatter 
plot in Figure 3.10 confirms this finding.  The difference in column performance 
is clear from the statistics calculated (Table 3.7). The mean HETP values for PPU 
are similar to 2-EP, with 2-EP showing marginally better performance as seen 












































Figure 3.9: Scatter plot showing the spread of N value for the 2-EP, PPU, CN 
columns for focused set. 
 
Table 3.6: Statistical data of N values of the peaks for stationary phases 2-EP, PPU, 
CN for focused set. 
N  2-EP  PPU  CN 
Mean  386  482  600 
Std Dev  196  436  697 









































Figure 3.10: Scatter plot showing the spread of HETP for the 2-EP, PPU, CN 
columns for focused set. 
 
Table 3.7: Statistical data of HETP of the peaks for stationary phases 2-EP, PPU, 
CN for focused set. 
HETP  2-EP  PPU  CN 
Mean  0.1729  0.1881  0.8219 
Std Dev  0.0989  0.1771  0.9658 
 
 
The scatter plot for the peak asymmetry values is shown in Figure 3.11. PPU 
appears to perform much better in this aspect, which is also confirmed by the 
statistics (Table 3.8); the mean value of PPU related data being very close to unity 
and  showing  smaller  scatter  compared  to  other  options.  The  asymmetry  data 
shows that the PPU column results in better chromatography for the peaks eluted. 
Overall  2-EP  comes  through  as  better  performing  column.  Although  the  data 
indicates 2-EP as the column of choice, compounds with specific substructures 
resulted in peak splitting. The peak splitting phenomenon has been explained in 
section 3.3.2 of this chapter.  














































Figure 3.11: Scatter plot showing the spread of asymmetry data for the 2-EP, PPU, 
CN columns for focused set. 
 
Table 3.8: Statistical data of asymmetry of the peaks for stationary phases 2-EP, 
PPU, CN for focused set. 
Asymmetry  2-EP  PPU  CN 
Mean  1.4535  0.8753  7.3021 
Std Dev  1.3387  0.4413  5.6184 
 
 
The  study  was  further  extended  for  the  diverse  library  set  of  compounds 
(Structures shown in Appendix 3 on pages 114-117). Here as seen in Figure 3.12, 
for the diverse set of compounds, 87 percent of the compounds eluted with 2-EP. 
Forty seven percent of the compounds did not elute within the runtime of 10 
minutes, under isocratic conditions of 20% methanol modifier, with CN columns. 
The peak shapes of the most of the compounds that did elute with the CN column 
were  broad  and  tailing.  The  asymmetry  values  for  most  compounds  analysed 
using  CN  column  show  tailing  peaks.  Similarly  with  PPU  column  several 
compounds were also found to have tailing peaks.    69 
Compound number



































Table 3.9: Values for k', N, HETP for 2-EP, PPU and CN columns of selected 
compounds of diverse set from Figure 3.12. 
  2-EP  PPU  CN 
Compound  k′ ′ ′ ′  N  HETP  k′ ′ ′ ′  N  HETP  k′ ′ ′ ′  N  HETP 
P1  3.55  1324.96 0.0377  3.75  1444.00 0.0346  1.05  747.11  0.0669 
P9  17.4  1874.38 0.0267  36.60  2279.68 0.0219  3.40  860.44  0.0581 
P15  7.35  1743.06 0.0287  4.70  1230.39 0.0406  1.60  256.00  0.1953 
P19  3.85  520.91  0.0960  1.90  318.48  0.1570  15.9  51.47  0.9713 
P23  3.95  542.61  0.0921  1.10  233.25  0.2144  3.90  141.10  0.3543 
P25  8.95  1584.04 0.0316  10.10  1166.48 0.0429  3.00  605.91  0.0825 
P29  37.4  2233.65 0.0224  0.85  18.94  2.6388  7.26  696.96  0.0717 
 
 
The N and HETP values are listed in Table 3.9 for selected compounds of diverse 
set. The scatter plot of N values for all the compounds in the diverse set is shown 
in Figure 3.13. The varied N data makes it difficult to determine the performance 
of  the  columns.  The  statistics  from  Table  3.10,  however,  indicates  marginally 
better  performance  of  2-EP  column  in  comparison  to  PPU  and  CN  columns. 
HETP data shown in scatter plot (Figure 3.14) indicates similarity in performance 
of 2-EP and CN columns. Although similar conclusions can be drawn from the 
statistics from HETP data (Table 3.11), CN column was eluting only half of the 



















































Figure 3.13: Scatter plot showing the spread of N for the 2-EP, PPU, CN columns 
for diverse set. 
 
 
Table 3.10: Statistical data of N values for stationary phases 2-EP, PPU and CN. 
N  2-EP  PPU  CN 
Mean  876  666  521 


















































Figure 3.14: Scatter plot showing the spread of HETP for the 2-EP, PPU, CN 
columns for diverse set. 
 
   71 
 
 
Table 3.11: Statistical data of HETP for stationary phases 2-EP, PPU and CN. 
HETP  2-EP  PPU  CN 
Mean  0.1709  0.6676  0.2191 
Std deviation  0.2943  0.9885  0.2645 
 
The peak asymmetry values (Table 3.12) indicate the good performance of 2-EP 
column which is further confirmed from the scatter plot in Figure 3.15 and the 
statistics from Table 3.13. The CN column also appears to show better results in 
peak asymmetry, however, with slightly larger standard deviation (larger scatter). 
Overall, for the diverse set 2-EP column shows good results in all the performance 
parameters analysed.  
 










Compound  2-EP  PPU  CN 
P1  0.97  1.03  1.05 
P9  1.09  1.10  0.85 
P15  1.13  11.74  1.31 
P19  1.70  1.72  1.89 
P23  1.55  1.97  2.46 
P25  0.94  0.99  0.46 




























































Figure 3.15: Scatter plot showing the spread of asymmetry data for the stationary 
phases 2-EP, PPU, CN for the diverse set. 
 
Table 3.13: Statistical data of asymmetry of the peaks for stationary phases 2-EP, 
PPU and CN. 
Asymmetry  2-EP  PPU  CN 
Mean  1.5038  2.8647  1.6620 
Std deviation  0.6525  3.3573  1.7009 
 
 
3.2.3  Additives 
 
Pure  modified  mobile  phase  may  not  be  sufficient  to  achieve  the  required 
chromatography. Distorted peak shapes and poor chromatography could be the 
result  of  certain  functional  groups  of  the  analyte  interacting  with  the  residual 
silanol groups. Higher concentrations of strong modifiers may improve efficiency 
but may also result in decreased retention and sensitivity.
103 The need to improve 
peak shapes prompted the addition of small amounts of additives to the mobile 
phase. Polar additives are generally immiscible in supercritical fluids. Hence these 
are added to the modifier and then introduced as a single fluid. The presence of 
additive  help  improve  the  peak  shapes  by  covering  the  active  sites  or  by 
suppressing the ionisation or ion pair formation by solutes. Additives may also, 
change the polarity of the mobile or the stationary phase.
25 Depending on the 
nature of the analytes additives can be acidic or basic compounds. Basic additives   73 
are  used  for  compounds  with  basic  functionality  and  acidic  additives  for 
compounds with acidic functionality. 
 
In this project the additives were generally added to modifiers when using the CN 
columns.  These  were  diethylamine  (DEA),  triethylamine  (TEA), 
dimethylethylamine (DMEA), tertbutylamine (TBA) and ammonium acetate. The 
presence of additives did not affect the peak shapes or retention on the 2-EP 
column. The small differences in retention times were observed from the results 
of  focused  library  for  different  additives  used  individually.  For  simplicity  the 
focused library was divided into groups based on the sub structures as shown in  
 
Table  3.14.  This  is  further  explained  in  detail  in  the  experimental  section  on 
page 98.  
 
 
Table 3.14: Differences in structures of the focused library 
Group  Compound 
numbers  Substructure 
A  EL1-EL8 
H2N
 
B  EL9-EL16 
H2N
 






Each compound from the focused set was analysed using isocratic 20% methanol 
modifier  with  0.1%  v/v  additive  on  CN  column.  A  secondary  amine,  diethyl-
amine, and two tertiary amines, triethylamine and dimethylethylamine, were used 
as additives on separate occasions. Figure 3.17 is a plot of retention times for all 
24  compounds  for  secondary  and  tertiary  amines.  All  the  compounds  with 
aliphatic side chain elute later in presence of a tertiary amine additive.    74 
Compound number





























Figure 3.16: Plot showing trends of secondary and tertiary amine additive for 









































































Figure 3.17: Trends Comparison of retention times of compounds using 0.1% DEA, 
TEA or DMEA as additive with 20% methanol modifier on 50mm CN column. 
 
A  similar  comparison  between  two  tertiary  amines  and  a  secondary  amine  is 
shown  for  group  A,  compounds  with  aliphatic  side  chains  and  group  C, 
compounds with aromatic side chains, in Figure 3.17. In both cases the retention 
times do not vary much for tertiary amines DEA and TEA, suggesting that the 
identity  of  an  amine  had  little  or  no  effect  on  the  retention  times.  But  when 
compared to with the retention times using DMEA, which is also a tertiary amine 
as additive, this is not true as E9 to E16 elute earlier with DMEA as seen in Figure 
3.18. These compounds were also found to be unstable in methanol, which may 
have an effect on the interaction of the solute with the stationary phase in the 
presence of DMEA.   75 
Compound number































Figure 3.18: Trends and comparison of retention times using primary, secondary, 
and tertiary amine additive. 
 
 Following  from  the  modifier  and  stationary  phase  studies  k',  N  and  HETP 
calculations were performed on the chromatograms of the additive study. These 
values for a selected list of compounds are shown in Table 3.15. The data on N 
values  and  HETP  appears  to  show  that  DEA  additive  performing  marginally 
better for most compounds. Similar is the case of HETP values.  
For  all  the  compounds  scatter  plots  were  generated  for  N  and  HETP  values. 
Figure  3.19  shows  variation  N  value  for  the  compounds  analysed;  except  for 
compound  EL13,  additive  DEA  shows  consistently  good  performance.  Other 
additives also show reasonably similar performance as seen from the figure; the N 
values for a compound are generally clustered together. The statistics of mean and 
standard deviation were also calculated to see if any more information can be 
obtained.  These  are  listed  in  Table  3.16.  The  additive  DEA  appears  to  show 
slightly better performance than other two additives analysed. The HETP values 
are  plotted  in  Figure  3.20;  except  for  compound  EL13  DEA  shows  good 
performance. The statistics for the HETP values are listed in Table 3.17. The 
performance  of  DEA  is  affected  by  one  outlying  value  of  EL-13  compound, 
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Table 3.15: Values for k', N, HETP for Additives DEA, TEA, DMEA for selected 
compounds from Figure 3.18. 
  DEA  TEA  DMEA 
Compounds  k'  N  HETP  k'  N  HETP  k'  N  HETP 
EL2  7.00  1024  0.0488  8.15  595  0.0840  8.55  744  0.0672 
EL5  8.60  1337  0.0374  9.95  978  0.0511  10.40  924  0.0541 
EL9  11.35  1015  0.0492  11.60  703  0.0711  9.50  689  0.0726 
EL14  15.75  302  0.1651  15.00  163  0.3052  9.65  129  0.3874 
EL19  5.55  1400  0.0357  4.60  1393  0.0359  4.45  1320  0.0379 















































Figure 3.19: Scatter plot showing the spread of N values for the additives DEA, 
TEA, DMEA. 
 
Table 3.16: Statistical data of N of the peaks for additives DEA, TEA, DMEA. 
N  DEA  TEA  DMEA 
Mean  836  698  720 








































Figure 3.20: Scatter plot showing the spread of HETP values for the stationary 
phases DEA, TEA, DMEA. 
 
Table 3.17: Statistical data of HETP of the peaks for additives DEA, TEA, DMEA. 
HETP  DEA  TEA  DMEA 
Mean  0.1097  0.0945  0.1159 
Std deviation  0.1767  0.0642  0.1308 
 
The peak asymmetry values are shown in Figure 3.21. The scattered values make 
it difficult to determine a single suitable additive. The statistics in Table 3.18 
shows marginally better performance of DMEA. In overall context, however, the 
performance of additives is comparable. Although the performance of additives is 
comparable, as expected, the effect of additives is clear from peak asymmetry 
which  is  much  improved  in  comparison  to  those  without  additive  on  the  CN 













































Figure 3.21: Scatter plot showing the spread of asymmetry data for the stationary 
phases DEA, TEA, DMEA. 
 
Table 3.18: Statistical data of asymmetry data of the peaks for additives DEA, TEA, 
DMEA. 
Asymmetry  DEA  TEA  DMEA 
Mean  2.5933  2.6821  2.2570 
Std deviation  1.5493  1.4896  1.0462 
 
More  recently  volatile  ammonium  salts  have  been  used  as  additives  for  basic 
compounds.
27, 108, 109 Ammonium salt additives were found to be compatible with 
mass spectrometric detection as they did not result in ion suppression as observed 
with acidic or basic additives. Figure 3.22 to Figure  3.24 below is one example 
showing the use of ammonium acetate as additive in comparison to using amine 
additive. Also shown is the chromatography in the absence of additive on the 250 
mm CN column. This particular compound structure of which is shown in Figure 
3.25, had mixed impurity. This could possibly be due the protecting group added 
during synthesis. In the absence of additive although the impurity peak separated 
from the compound peak, the compound peak was broad and tailing. The impurity 
peak appears around 8 min as seen in the mass spectrum. The addition of an 
amine  additive  improved  the  peak  shape  but  also  moved  the  retention  of  the 
impurity. This resulted in the two peaks eluting very close to each other making it   79 
difficult to separate. Using ammonium acetate not only improved the peak shape 
but also resolved the impurity peak form the compound peak. 
 






























420 419 403  
Figure 3.22: 250 mm CN column, 25% methanol, Flow: 4 mL min
-1 with no additive, 
showing separation of impurity (m/z = 379) from compound peak (m/z = 365).   80 
 
 
































Figure 3.23: 250 mm CN column, 25% methanol, Flow: 4 mL min
-1 with 0.1% DEA 
additive, showing separation of impurity (m/z = 379) from compound peak (m/z = 
365). 
 




























Figure  3.24: 250 mm CN column, 25% methanol, Flow: 4 mL min
-1 with 0.6 mM 
ammonium acetate additive, showing separation of impurity (m/z = 379) from 
compound peak (m/z = 365). 









Mol. Wt.: 364.40  
Figure 3.25: Structure of EL6. 
 
Why use Isocratic chromatographic condition? 
 
The training set of compounds were first analyzed with isocratic conditions and 
then analyzed with gradient conditions in an attempt to reduce the analysis time. 
Similar conditions were then used for the focused library of compounds. These 
conditions were found to be unsuitable for this set of compounds as the peaks 
showed poor chromatographic properties i.e. peak splitting. Figure 3.26 (a) is an 
example of the SFC chromatogram with 50mm 2-EP, 5-55% methanol gradient @ 
10% min
-1, 3mL min
-1 flow. Hence all the compounds were then analyzed with 
isocratic conditions as the peaks were now comparatively sharp and narrow as 
shown in Figure 3.26 (b) with 50mm 2-EP, 20% methanol @ 3 mL min
-1 flow. 
Hence the isocratic condition of 20% methanol modifier was used in these studies.  
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(b)   82 
Table 3.19: N and HETP values for Figure 3.26. 
  N=16(tr/w)
2  HETP=L/N 
(a)  318.7531  0.1569 
(b)  400.0000  0.1250 
 
Table 3.19 lists N and HETP values for the chromatograms shown in Figure 3.26. 
Not  only  helping  reduce  peak  splitting,  isocratic  conditions  appear  to  help 
improve N value and HETP value for the compound considered. Summarising the 
above results, two possible generic methods can be put forward. First using 50 
mm 2-EP columns with 20% methanol modified CO2 mobile phase at 3 mL min
-1 
flow rate, pressure 100bar and oven temperature of 40ºC. The second method uses 
conditions  similar  to  the  first  with  a  50  mm  CN  column.  Further  0.1  M 
concentration  of  ammonium  acetate  additive  is  added  to  the  20%  methanol 
modified mobile phase mobile. The presence of an amine additive may  cause 
difficulty in preparative chromatography during isolation of target compound. 
 
3.3   Difficulties encountered in SFC 
 
In  the  given  set  of  compounds  some  were  insoluble  in  methanol  which  was 
initially  considered  to  be  major  problem.  A  solution  to  this  is  explained  in 
section 3.3.1.  A  group  of  compounds,  with  specific  substructures  cause  peak 
splitting phenomenon or elute with two peaks. This is the major issue with this 
method and is discussed in detail in section 3.3.2.   83 


























Figure 3.27: Structures of compound insoluble in methanol (Mix 1). 
 
The insolubility of some compounds in methanol required a different approach to 
be investigated. The training set included three compounds that were insoluble in 
100% methanol. See Figure 3.27. First attempt of dissolving these compounds in 
methanol by sonicating or warming the solutions was unsuccessful. Out of the 
three compounds two of them were soluble in DCM, this solution was further 
diluted with methanol and analysed by SFC.  
 
Both of these compounds, prepared in DCM and methanol mixture, eluted from 
the  2-EP  column  with  good  peak  shapes  (Figure  3.28  a,  c).  The  results  were 
confirmed by MS data (Figure 3.28 b, d). This shows that compounds initially 
insoluble in methanol can still be analysed by SFC. Further on in this project 
several  more  such  compounds  were  analysed  using  a  mixture  of  DCM  and 
methanol for sample preparation. 

















































Figure 3.28: Chromatograms showing single peak when prepared using mixture of 
DCM and methanol (a) SFC chromatogram of GSK3, (b) MS data confirming 
GSK3, (c) SFC chromatogram for GSK4, (d) MS data confirming GSK4. 
 
One of the compounds in the training set was Ampicillin (GSK10). It is known 
that Ampicillin can be analysed by liquid chromatography.  Michael Margosis 
used reversed phase HPLC for the analysis of ampicillin to test the potency of 
trihydrate and anhydrous forms of ampicillin and its sodium salt. Acid phosphate 
acetonitrile was used for mobile phase
110. Extracted and derivatised samples were 
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reverse phased ODS column was used with acetonitrile, methanol and phosphate 
buffer as mobile phase. A Fluorescent detector was used for detection
111.  Kumar 
et al. developed a method to separate ampicillin and another drug cloxacillin from 
their degradation products using a reversed phase C18 column and acetonitrile 
phosphate buffer mobile phase
112. 
 
Ampicillin was only soluble in a mixture of 50:50 acetonitrile/water. The stock 
solution  was  diluted  with  methanol  and  analysed  by  SFC-MS  where  the 
compound  did  not  elute  on  any  of  the  stationary  phases  under  any  of  the 
experimental  conditions  used.  Diluting  the  stock  with  a  mixture  of  50:50 
acetonitrile/water made no difference to the elution, nor did using acetonitrile as 
the modifier. This lack of results could be due to the zwitterionic nature of the 
compound.  Ampicillin  was  also  not  amenable  to  analysis  with  SFC-MS.  This 
shows that not surprisingly the solubility of samples in the mobile phase is a 
critically  important  factor  in  SFC.  The  samples  need  to  be  either  soluble  or 
partially  soluble  and  compatible  with  the  mobile  phase  composition  to  some 
extent. 
 
3.3.2  Peak Splitting 
 
A drawback of using 50mm 2-EP column for analysis was observed. During the 
initial analysis of the training set two peaks were observed for compounds with 
specific substructure highlighted in red in Figure 3.31. Several trials were carried 
out using 50 mm columns, these columns having the same packing as the 250 mm 
column used. Initially the columns separated the mixtures but on continued use of 
the column peak splitting was observed. Overloading of the sample on the column 
was eliminated as diluting the solution had no effect. Other possibility of fault in 
the packing of stationary phase material was considered when the second column, 
of  the  same  lot  number,  did  not  show  any  peak  splitting.  But,  then  this  was 
disregarded as after a few injections the phenomenon was repeated. Example of 
the split peak is shown below in Figure 3.29. This phenomenon was noticed for 
compounds with specific substructure shown in red in Figure 3.31. Altering the 
modifier conditions, i.e. changing the percentage modifier, made no difference to   86 
peak splitting and neither did reducing the flow rate from the default instrument 
setting of 4 mL min
-1 to 2 mL min
-1. The problem with the peak splitting for this 
particular compound, shown in Figure 3.29 (b), was resolved by changing the flow 
rate  from  constant  conditions  to  gradient  conditions,  1  mL  min
-1  hold  for 
0.5 minutes, 4 mL min
-1 @ 8 mL min





























































10-3GRADMIXE7 65 (1.217) Scan ES+ 
5.02e4 408
214
200 180 170 111 126 143 231 381 363 350 267 249 296 282 322 311 396 438 426
10-3GRADMIXE7 68 (1.272) Scan ES+ 
5.07e4 408
214 200 126 114 181 170 155 142 231 381 363 349 268 243 258 316 289 301 339 329 395 437 424
 
 
Figure 3.29: (a) Single peak of GSK6 with a new column is used (b) after a few 
analyses with exactly same conditions the peak splits into two. (c) MS data showing 










































































STD3. Terfenadine  
Figure 3.31: Structures of compounds exhibiting peak splitting. Similarity in 
structures is shown in red colour. 
 
This  was  further  explored  and  as  a  result  of  discussion  possible  reasons  and 
explanations  was  put  forward.  These  were  to  check  for  any  isomers  or 
stereoisomers, to explore the pH of the mobile phase, to try and separate the peaks 
and to test if the peaks are due to solvation of compound. 
 
The compounds were analysed on a generic chiralpak AD-H column on the SFC. 
This  resulted  in  a  single  peak.  Since  no  conclusion  could  be  drawn  from  the 
results, next the effect of the pH of the mobile phase was explored. 
 
It is known that, in HPLC analytes show irregular peak shapes such as fronting, 
tailing or sometimes peak splitting when the pH of the mobile phase is ±2 units of 
pKa  of  the  compound.
113  But  as  the  mobile  phase  in  SFC  is  CO2-MeOH,  an 
attempt to alter the pH of the CO2-MeOH mobile phase was made by changing the 
modifier and additive concentrations. This did not result in any improvement.  
 
Further an attempt to separate the peaks was made so as to characterise the two 
peaks.  In  order  to  separate  them  the  instrument  was  switched  over  to  mini- 
preparative mode from analytical mode. The difference between the two modes is 
the introduction of the sample into the chromatographic system. In an analytical 
mode  the  sample  is  injected  into  a  premixed  mobile  phase  of  CO2-MeOH,   88 
whereas in preparative mode the sample gets injected in the modifier and then 
together introduced into a stream of CO2. The schematic of both the plumbing 
systems are shown in Figure 3.32 and Figure 3.33.  
 
 
Figure 3.32: Schematic of the plumbing configuration for the operation of Berger 




Figure 3.33: Schematic of the plumbing configuration for the operation of Berger 
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0.5 mm path length cell   89 
 
The samples were prepared for the procainamide and GSK6 and analyzed using 
the preparative mode for sample injection, i.e. directly into the organic modifier 
prior to mixing with the supercritical CO2. Initially the conditions used were same 
as that used for the analytical mode. Figure 3.34 and Figure 3.35 show the UV 
chromatograms and the corresponding MS data for procainamide when analyzed 
analytically and then in the preparative set-up. The chromatograms indicate that 
the compound gives two peaks in the analytical mode whereas a single sharp peak 
is observed in the preparative mode.  
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Figure 3.34: (a) UV chromatogram of procainamide showing peak splitting using 
analytical mode injection mode. Corresponding MS data showing; (b) RIC for 
procainamide (c) mass spectra for each split peak. 
 
Similarly more compounds were analyzed in both modes but in each case the 
results  were  similar  to  that  observed  with  procainamide,  this  confirming 
improvement of injection into the organic phase. Shown below in Figure 3.36 are   90 
the UV chromatograms of GSK compound 6 for the two injection modes and 
again a single peak was observed in the preparative injection mode, using the 
same column and exactly the same chromatographic conditions.  
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Figure 3.35: (a) UV chromatogram of procainamide showing single peak using 
preparative injection mode. Corresponding MS data showing (b) RIC for 
procainamide (c) mass spectra of the peak. 
 
 
Analysis of the group of compounds, which resulted in peak splitting, with on 
50 mm 2-EP column resulted in two peaks which were initially thought to be as 
peak splitting as the MS data showed identical ionisation for both peaks. This was 
further confirmed by in source CID-MS. Hence an attempt to obtain a single peak 
was made. This was carried out by injecting the sample at the lowest flow rate 
possible and then further ramping it to the required flow rate. Since this did not 
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Figure 3.36: UV chromatograms for GSK compound 6 when analyzed in analytical 
and in preparative mode showing peak splitting and single peaks respectively. 
 
 
Another  possibility  was  that  of  one  of  the  peak  due  to  the  solvation  of  the 
molecule with methanol. One of the samples was prepared in different solvents 
and then analyzed with two different modifiers. Figure 3.37 and Figure 3.38 show 
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Figure 3.37: Using 20% methanol as modifier, chromatograms of procainamide 
sample prepared in different solvents (a) methanol, (b) ethanol, (c) DCM, (d) 2-
propanol, (e) DMSO and (f) DMSO + methanol. 
 
 
The  peak  splitting  or  two  peaks  were  observed  when  a  sample  prepared  in 
methanol was analyzed using methanol modifier. A similar effect was observed 
when DMSO was used for sample preparation. This suggested that methanol or 
DMSO form solvated species which cannot be differentiated in an electrospray 
ionisation  process.  Single  tailing  peaks  were  obtained  using  ethanol  modifier. 
From the above chromatograms it was also noticed that the peaks were narrower 
and  comparatively  symmetrical  (peak  asymmetry  =  0.95  and  peak  width 
methanol 
2-propanol 
  DMSO + methanol 
ethanol 
DCM 
DMSO  Compound   
peak 
DMSO 
peak   93 
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Figure 3.38: Using 20% Ethanol as modifier, chromatograms of procainamide 
sample prepared in different solvents (a) methanol, (b) ethanol, (c) 2-propanol and 
(d) DCM.  
 
 
During the additive study, it was noticed that the peaks did not split on addition of 
0.6 mM NH4OAc to the mobile phase. This is illustrated in Figure 3.39. This may 
be due to the fact that addition of ammonium acetate would deactivate the silanol 
groups  and  therefore  favour  the  second  mechanism  i.e.  interaction  with  the 
positively charged nitrogen. The purpose of adding additive to the mobile phase is 
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Figure 3.39: Chromatograms showing improved peak shapes for compounds 
terfenadine and GSK 2 on addition of NH4OAc additive.  
 
3.4  Possible Trend with the bpKa1 values 
 
The  data  for  log  P,  log  D  and  pKa  for  the  focused  set  provided  with  the 
compounds were used to find trends with the physico-chemical properties. The 
compounds were analysed using a CN column with 20% MeOH-CO2 modifier 
and 0.1% amine additive. The retention times were then plotted in combination 
with physico-chemical properties in an attempt to find a trend. The bpKa1 values 
of the compounds may show a trend in relationship between compound type and 
elution from column.  
 
The plots in Figure 3.40 showed that compounds EL17 to EL24, i.e. group C of 
focused  set,  with  imidazole  substructure  with  lower  bpKa1  elute  early  in 
comparison to the compounds with the aliphatic amine substructure. This suggests 
that may be a correlation with the bpKa1 values and retention times. EL22 is an 
exception though this may be due to the presence of the acid functionality on a 
side chain. More samples with similar structures need to be investigated to see 
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Figure 3.40:(a) Plot of compound number against retention time, (b) Plot of 
compound number against bpKa1 value. 
 
3.5   Comparison  of  SFC  and  HPLC  for  the  given  set  of 
compounds 
 
Due to the advantages of SFC over HPLC, one of the aims of the project was to 
compare SFC and HPLC for compounds of pharmaceutical interests. The results 
from the SFC method development suggest the requirement of small amounts of 
additive to the CO2 / MeOH mobile phase to improve the elution of compounds. 
Like wise the generic HPLC method used TFA. The study was undertaken by 
analysing  the  focused  and  the  diverse  set  with  the  methods  mentioned  in  the 
experimental section. For convenience the plots are split into four groups. The 
first  plot  consists  of  the  focused  library,  Figure  3.41.  Here  for  this  class  of 
compounds  SFC  was  the  preferred  technique  as  the  generic  HPLC  method 
compound number

























































 (b)   96 
required 8min for the compounds to elute compared to 3.5 minutes with SFC. 
Moreover using HPLC the compounds EL11 of EL24 were not retained on C18 
column and eluted with the solvent front. In contrast all the 24 compounds eluted 
with  SFC  on  a  50  mm  CN  column,  using  an  additive,  within  3.5  minutes. 
Although  the  retention  time  is  short  the  peaks  are  clearly  separated  from  the 
solvent front as the injection peak. This shows that SFC gives greater compound 
coverage compared to HPLC for this class of compounds and is also significantly 
faster with comparable peak properties. 
Compound number





























Figure 3.41: HPLC and SFC comparison for the focused library. 
 
Similarly,  the  diverse  set  of  compounds  was  also  analysed  on  both  SFC  and 
HPLC and the results are given the figures below. Figure 3.42 and Figure 3.43 
show that 83% compounds elute with 2-EP column on SFC in comparison to 95% 
by HPLC by generic C18 HPLC method. 4% of the compounds did not elute by 
HPLC or SFC. Two compounds elute with the solvent front by HPLC. Figure 
3.44 shows that 87% compounds elute with 2-EP column on SFC in comparison 
to 97% by HPLC by generic C18 HPLC method. EL11 eluted only by SFC. 70% 
compounds elute within 2.5 min in comparison to 8 min by generic C18 HPLC 
method. Summarising the results with a Venn diagram in shown Figure 3.47, it 
can be concluded that both techniques are complementary to each other and that 
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Figure 3.42: HPLC and SFC comparison for the diverse set I (Structures shown in 
Appendix 3, pages 114-117). 
Compound number






























Figure 3.43: HPLC and SFC comparison for the diverse set II (Structures shown in 
Appendix 4, pages 117-119). 
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Figure 3.44: HPLC and SFC comparison for the diverse set II (Structures shown in 





   98 
3.6  Experimental Section  
 
Materials and Reagents 
 
SFC grade CO2 from BOC gases (Guildford, UK) was used for mobile phase. 
HPLC grade methanol from Fisher Scientific (Loughborough, UK) was used for 
modifier  unless  specified.  TFA,  Diethylamine  (DEA),  triethylamine  (TEA), 
dimethylethylamine (DMEA) and ammonium hydroxide were used as additives 
were obtained from respectively. 2-propanol, ethanol and acetonitrile also used for 
mobile phase were all HPLC grade from Fisher Scientific (Loughborough, UK). 
DCM and DMSO were also used for sample preparation. These solvents were 
used  for  both  sample  preparation  and  as  modifiers.  A  training  set  of  20 
compounds  was  provided  by  GSK,  and  a  second  set  of  structurally  related 
compounds, focused library, was provided by Eli Lilly. Compounds from Pfizer 
and  Evotec  were  combined  as  the  diverse  set.  Focused  library  from  Eli  Lilly 







































R1= H, CH(CH3)2, CH2C6H5, 
       CH2OH, CH2COOH   
 
R2= (CH2)2NH2, (CH2)3NH2,    99 
Stationary phases 
 
The  stationary  phases  used  are  2-ethyl  pyridine  (2-EP),  2-pyridyl  propyl  urea 
(PPU), cyano (CN) and Diol. The structures of these are shown in Figure 3.46. 
The  4.6  mm x 250  mm  (6µ  particle  size)  columns  were  provided  by  Mettler-
Toledo AutoChem. This set did not include PPU. The 4.6 mm x 50 mm (5µ 























SFC analysis was performed on a Berger Minigram (Mettler-Toledo Autochem, 
Newark, DE, USA) system equipped with a FCM-1100/1200 dual pump fluid 
control  module,  a  TCM-2250  heater  control  module,  an  ALS  3100/3150 
autosampler  and  a  Kauner  k-2501  variable  wavelength  UV  detector  (Kauner, 
Berlin, Gemany). The UV detector is set at 250 nm for the GSK set and at 230 nm 
for the Eli Lilly set of compounds. The mass spectrometer coupled to SFC was 
initially a Platform II and was replaced by Micromass platform LCZ both donated 
by GSK. A HP1050 HPLC system (Agilent, Palo Alto, California) was used to 
deliver  a  make  up  flow  of  0.1  mL  min
-1  of  methanol  to  the  MS.  The  SFC 
instrument  is  controlled  by  the  SFC  PRONTO  software  (v 1.5.305.15,  Berger 
instruments) and the MS is controlled by MassLynx software (v 3.5). The HPLC-




The  experimental  condition  for  each  gradient  and  isocratic  methods  are  given 
below.  The  samples  were  generally  prepared  in  HPLC  grade  methanol  unless 
specifically mentioned. Compounds insoluble in methanol were prepared in DCM 
and further diluted with methanol. One of them, GSK10 was prepared in a 50:50 
mixture  of  acetonitrile  and  water.  Compounds  from  Pfizer  were  supplied  as 
100 µg/mL solutions in 1:9 DMSO: MeOH solvent mixture. All samples analyzed 
on SFC-MS system are of approximate concentration 100 µg/mL. 
 
Table 3.20: Chromatographic conditions for the GSK and Eli Lilly compounds 
(SFC). 
Conditions  Gradient method  
 
Isocratic method  
Modifier  5-50% MeOH @ 20% min
-1  20% methanol 
Additive  0.1% v/v of  one of 
DEA, TEA, DMEA 
0.1% v/v of one of 
DEA, TEA, DMEA, TFA 
Flow  1.5 mL min
-1 hold 0.5 min up 




Pressure  100 bar  100 bar 
Column oven 
temperature 
35°C  35°C 
Wavelength  254 nm  230 nm 
 
Table 3.21: Chromatographic conditions for the SFC and HPLC. 
Conditions  SFC  HPLC: XTerra
TM Waters 
Modifier  Isocratic 20% MeOH  5 minute gradient from 95% 
water to 100% MeOH at 
1.25 mL min
-1 hold 100% 
MeOH for 10 min 
Column  250 mm CN  C18 5 µm 3.0 mm x 50 mm 
Additive  0.1% v/v of one of 
DEA, TEA, DMEA, TFA 
 
Flow  4 mL min
-1  1.5 mL min
-1 
Pressure  100 bar   
Column oven 
temperature 
35°C  35°C 
Injection 
volume 
2 µL  10 µL 
Wavelength  230 nm  230 nm 
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3.7  Conclusions 
 
In order to have a generic SFC method for pharmaceutical type of compounds 
methanol  was  the  most  appropriate  modifier.  Samples  need  to  be  soluble  or 
compatible with the mobile phase composition. This was confirmed by replacing 
methanol with ethanol, 2-propanol, and comparing the results with other choices.  
 
2-EP was found to be compatible with most compounds except for those with 
certain substructures. This problem can be fixed using DCM as solvent for sample 
preparation or ammonium acetate in the mobile phase. CN and diol columns also 
give good results only with addition of additive in the mobile phase. The use of 
amine additive may cause difficulty preparative chromatography. 
 
The identity of an amine additive has little or no effect on the retention times. 
Ammonium acetate would be the preferred choice of additive as it is also MS 









Finally the SFC and HPLC comparison results can be summarised with the Venn 
diagram shown in Figure 3.47. Around 76% of the total compounds analysed in 
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small percentage i.e. two compounds from the set eluted neither by HPLC nor by 
SFC. Out of the remaining 22% nearly 14% were analysed only by SFC. These 
results  indicate  that  the  two  techniques  are  definitely  complementary  to  each 
other. However, since the instrumentation of SFC is a modification of HPLC, 
when required it can be used like an LC by using 100% modifier as the mobile 
phase. This could cut down the costs of two different instruments.    103 
Chapter 4  
Conclusions and Future Work 
 
Supercritical fluid chromatography is a normal phase technique orthogonal to the 
most  commonly  used  high  performance  liquid  chromatography.  Supercritical 
fluids  have  liquid  like  diffusivity  and  gas  like  viscosity  which  speeds  the 
separation process. Commonly used alcoholic mobile phase are also MS friendly. 
Detection  using  MS  is  more  selective  to  most  other  detectors  used.  SFC  was 
found to be compatible to all API techniques. In this project the two aspects of 
SFC were researched. One of them was the coupling of SFC to ESI-MS and the 
other was to optimize the SFC parameters in an attempt to achieve a  generic 
method for the analysis of pharmaceutical type of compounds.  
 
Samples ionized in the absence of high voltage, when SFC was coupled to ESI-
MS. To understand the mechanism involved in this type of ionization, compounds 
1-7 (see Figure 2.1) were analysed using SFC-ESI-MS under normal electrospray 
conditions  and  with  high  voltage  switched  off  (Novo  spray.  Addition  of 
ammonium acetate or acid to the make-up solvent did not enhance ionization, thus 
ruling out the possibility of thermospray type or charged residue model type of 
ionization  mechanism.  But  with  pure  methanol  as  make-up  solvent  study  of 
systematic increase in the high voltage from 0 to 5kV resulted in little variation in 
sensitivity suggesting the presence of pre-formed ions in solution similar to that of 
charge residue model (CRM). 
 
Novospray was found to be dependent on the SFC parameters such as pressure, 
modifier and flow rate, but was independent of the API source. Novospray was 
also observed when ESI source was replaced with APCI source. Here novospray 
can be compared to sonic spray in which ionization is independent of heat or 
electricity. In sonic spray ionisation a coaxial nitrogen gas to the analyte solution 
facilitates droplet nebulisation. A comparative study of acetonitrile and methanol 
as  modifiers  suggests  that  the  slight  acidic  nature  of  methanol  may  assist  in   104 
protonation on the molecule. Once again this leads to CRM type of mechanism. 
Based on the experimental study a definitive mechanism could not be determined, 
however, novospray may be described as a variant of sonic spray with a charge 
residue  model-type  formation  of  analyte  ions  is  a  likely  mechanism.  Another 
possibility is that the ions are formed due to collision of molecules in the free jet 
expansion  of  the  SFC  eluent.  An  important  point  to  note  is  that  increased 
sensitivity can be achieved, in the absence of source HV, when using SFC-MS 
system with methanol modified CO2 mobile phase. This ultimately can assist in 
lowering the limit of detection for such compounds as shown in Figure 2.13 for 
oxybutynin. 
 
In the second part of the project SFC parameters were explored in an attempt to 
develop a generic method for pharmaceutical type of compounds. The various 
parameters of SFC such as modifiers, column materials, additives were studied 
and the most suitable were chosen. 
 
 Methanol,  ethanol  and  propanol  were  tried  as  modifiers  for  a  set  of  training 
compounds  and  from  the  results  obtained  methanol  was  chosen  as  a  suitable 
modifier.  The  modifier  and  pressure  studies  for  the  Novospray  ionisation 
suggested 20 to 30% of modifier generally resulted in better ionisation. Also 100 
bar pressure was found to be optimum.  
 
Focused and diverse sets of compounds were analysed with different columns 
such as 2-EP, Cyano, Diol and PPU. 2-EP column was found to be compatible 
with most compounds giving shorter retention times with reasonably good peak 
shapes accept for analytes with certain substructures. These analytes exhibited 
peak  splitting.  Further  experiments  suggest  that  these  analytes  result  in  the 
formation of a solvated molecule resulting in a second peak. Use of DCM in the 
sample  preparation  stage  eliminated  peak  spitting.  Another  solution  was  to 
introduce ammonium acetate as additive in the modifier. CN and Diol columns 
give good results on addition of additive to the modifier. This may be analytically 
acceptable,  but  the  use  of  amine  additive  may  cause  difficulty  preparative 
chromatography. The identity of an amine additive has little or no effect on the   105 
retention times. Ammonium acetate would be the preferred choice of additive as it 
is also MS compatible and easier to separate compared to amines. 
 
SFC  and  HPLC  comparison  results  were  summarised  with  the  Venn  diagram 
shown in Figure 3.47. Both techniques were found to be complimentary to each 
other with a large percentage of compounds compatible. A very small percentage 
i.e. two compounds from the set eluted neither by HPLC nor by SFC. Out of the 
remaining compounds, nearly 2/3
rd of compounds could be analysed by SFC alone 
and  the  rest  of  the  compounds  by  HPLC  alone.  However,  since  the 
instrumentation of SFC is a modification of HPLC, when required it can be used 
like an LC by using 100% modifier as the mobile phase. This could cut down the 
costs  of  two  different  instruments.  SFC  was  found  to  give  greater  coverage 





The work undertaken in this thesis used a limited set of compounds to understand 
the ionisation mechanism in the absence of high voltage. To explore whether this 
phenomenon is valid for wider range of compounds a further study with diverse 
set of compounds is required.  
 
The experiments with the focused set showed co-relation between retention times 
and the pkb1 values of the compounds. Due to Eli Lilly withdrawing out of the 
project,  the  research  could  not  be  progressed  in  this  area.  There  is  scope  for 
undertaking experiments to understand the relation between retention time and the 
physical properties. 
 
Additives  study  using  the  focused  set  showed  some  correlation  between  the 
chemical structures and the nature of the additive used. Detailed study in this area 
with compounds sets very closely related in their chemical structures is required. 
 
Lastly,  both  SFC  and  HPLC  techniques  were  seen  to  perform  well  for  most 
compounds  analysed.  More  experimental  work  is  required  to  clarify  the   106 
overlapping area based on chemical space or physical properties or combination 
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Mol. Wt.: 320.39  
EL2. C18H28N4O3
Mol. Wt.: 348.44  
EL3. C18H26N4O3





























Mol. Wt.: 336.39  
EL5. C19H28N4O3
Mol. Wt.: 360.45  
EL6. C17H24N4O5


























Mol. Wt.: 396.48  
EL8. C15H22N4O3
Mol. Wt.: 306.36  
EL9. C15H22N4O3



























Mol. Wt.: 334.41  
EL11. C17H24N4O3
Mol. Wt.: 332.40  
EL12. C15H22N4O4




























Mol. Wt.: 346.42  
EL14. C16H22N4O5
Mol. Wt.: 350.37  
EL15. C21H26N4O3



























Mol. Wt.: 292.33  
EL17. C16H19N5O3
Mol. Wt.: 329.35  
EL18. C18H23N5O3






























Mol. Wt.: 355.39  
EL20. C16H19N5O4
Mol. Wt.: 345.35  
EL21. C19H23N5O3






























Mol. Wt.: 373.36  
EL23. C22H23N5O3
Mol. Wt.: 405.45  
EL24. C15H17N5O3
Mol. Wt.: 315.33  
 
 













Mol. Wt.: 343.46 
GSK2.N1-[2-(diethylamino)ethyl]-
4-aminobenzamide











Mol. Wt.: 347.41  
GSK4.2,5-di(5-tert-butylbenzoxazole-2-yl)
thiophene

















Mol. Wt.: 333.38  
GSK6. Trifluoperazine
(dihydrochloride)













Mol. Wt.: 266.34  
GSK8. N-benzoyl-L-Tyrosineethyl ester




















Mol. Wt.: 372.21  
GSK10.Ampicillin














Mol. Wt.: 277.36  
GSK12. (S)-(-)-sulpiride















Mol. Wt.: 347.29  
GSK14. N-[(R)-1-(10-naphthyl)-ethyl]-
phthalamic acid




















Mol. Wt.: 368.84  
GSK16. 2-(4-chloro-3-nitrobenzoyl)
benzoic acid





























Mol. Wt.: 330.74  
GSK18. Boc-Asp(oBzl)-OH
















Mol. Wt.: 369.45  
GSK20. N-benzyl-4-chloro-5-
sulphomoylanthranilic acid
Mol. Wt.: 340.78  
 
 










P1 : 5-(4-methylphenyl)- 
5-phenylhydantoin
Mol. Wt.: 266.3  
P2 : Acetanilide


















Mol. Wt. : 383.9 (free base) 
P4 : Amitriptyline HCl






















Mol. Wt. : 408.9 (free base) 
P6 : Caffeine












Mol. Wt.: 295.7  
P8 : Chlorpeniramine















P9 : Chlorthalidone 
Mol. Wt.: 338.77  
P10 : Cortisone
Mol. Wt.: 360.44 
P11 : CP-052608










Mol. Wt. : 291.2  
P12 : Diltiazem















Mol. Wt.: 306.27  
P14 : Ibuprofen











Mol. Wt. : 281.3  
P16 : Ketoprofen










Mol. Wt.: 328.41 
P18 : Mianserin













Mol. Wt.: 480.53  
P20 : Nortryptyline
















P21 :  Furosemide
Mol. Wt.: 330.74  
P22 : Salbutamol





















Mol. Wt.: 474.58 
P24 : sulphadimethoxine













Mol. Wt.: 253.28  
P26 : Suprofen
















P27 : Thioflavin T
Mol. Wt.: 283.41  
P28 : Triamcinolone














P30 : UK 11147
Mol Wt.: 257.12 
P29 : Trichloromethiazide
Mol. Wt.: 380.66  
P30 : UK 11147








Mol. Wt.: 454.60 
 















E1: 0773_00005 [A161] 
C16H23NO4
Mol. Wt.: 293.36 
E2: 0773_00006 [A162] 
C16H15NO4











E3: 0773_00007 [A163] 
C20H31NO4
Mol. Wt.: 349.46 
E4: 0773_00008 [A164] 
C20H23NO4
Mol. Wt.: 341.40 
 








O O  
E5: 0773_00009 [A165] 
C20H18N4
Mol. Wt.: 314.38 
E6: 0773_00010 [A166] 
C17H18N4O2









E7: 0773_00011 [A167] 
C23H18N4
Mol. Wt.: 350.42 
E8: 0773_00012 [A168] 
C23H18N4










E9: 0773_00013 [A169] 
C28H21N3
Mol. Wt.: 399.49 
E10: 0773_00014 [A170] 
C22H17N3S









E11: 0773_00016 [A172] 
C21H19N3
Mol. Wt.: 313.40 
E12: 0773_00017 [A173] 
C25H21N3










E13: 0773_00018 [A174] 
C22H21N3O2
Mol. Wt.: 359.42 
E14: 0773_00019 [A175] 
C19H15BrN4

















E15: 0773_00020 [A176] 
C24H18BrN3
Mol. Wt.: 428.32 
E16: 0773_00038 [A178] 
C25H29N5O2
Mol. Wt.: 431.53 
N N
OH HO




E17: 0773_00040 [A180] 
C12H12N2O2
Mol. Wt.: 216.24 
E18: 0773_00041 [A181] 
C14H12N2O4



















E19: 0773_00043 [A183] 
C18H34N4O2
Mol. Wt.: 338.49 
E20: 0773_00037 [A187] 
C18H19ClN4O











E21: 0773_00052 [A188] 
C24H24N2O2
Mol. Wt.: 372.46 
E22: 0773_00053 [A189] 
C14H13NO










E23: 0773_00054 [A190] 
C12H15NO2
Mol. Wt.: 205.25 
E24: 0773_00055 [A191] 
C20H22N2O2















E25: 0773_00056 [A192] 
C19H26N2O2
Mol. Wt.: 314.42 
E26: 0773_00057 [A193] 
C17H22N2O4
















E27: 0773_00058 [A194] 
C19H22N2O2S
Mol. Wt.: 342.46 
E28: 0773_00059 [A195] 
C16H26N2O4

















E29: 0773_00060 [A197] 
C17H24N2O3
Mol. Wt.: 304.38 
E30: 0773_00061 [A198] 
C14H24N2O5








E31: 0773_00087 [A200] 
C24H24N2O
Mol. Wt.: 356.46 
E32: 0773_00088 [A201] 
C22H22N2OS







E33: 0773_00089 [A202] 
C10H14N2OS
Mol. Wt.: 210.30 
E34: 0773_00090 [A203] 
C12H18N2OS







E35: 0773_00091 [A204] 
C14H22N2OS
Mol. Wt.: 266.40 
E36: 0773_00092 [A205] 
C28H26N2O








E37: 0773_00093 [A206] 
C26H24N2O2
Mol. Wt.: 396.48 
E38: 0773_00094 [A207] 
C28H32N2O



















E39: 0773_00099 [A208] 
C14H19ClN2O2S
Mol. Wt.: 314.83 
E40: 0773_00100 [A209] 
C11H13ClN2O2S













E41: 0773_00101 [A210] 
C15H16N2O
Mol. Wt.: 240.30 
E42: 0773_00102 [A211] 
C12H18N2O







E43: 0773_00103 [A212] 
C16H18N2O
Mol. Wt.: 254.33 
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